ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0001382.1|Svaricin_1 # 2 # 1003 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.735	BGC0001382.1|Svaricin_1 	2	1003	-	Loose	540	26.1794	OXA-157	31.58	3001462	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCGCAGCTACGGCACCTACGTGGACGGACACGAGCGGCCCTCGGACAAGTGGGTCTACACCGTGCACTCGTCGGCGATGCTGCGGGACACGATGGGCTCGGTCCGGCTCAAACGGGGCCTGGAGCGGGGCCGGATCGCACCGGAGGCCGCCACGGACGACGTGGTCGGCCGGGTGGCGGTCGGCGACGGCCACGACATGGACGCGGCTCTCCACGTCGCCGCGGGTGCGGCCCGGGCCTGGTCGGCGGTTCCGCCGGCCGCCCGGCTGCGGGTGGTGGAGGAGTTCCACCACCTCGTCCGCGAGAAGAGCGCCGAGATCATCGACGTGATGGTCGCCGAGGGCCACCCCCGGATGCTCGCCCGCTGGGAGGTCGCCGGGATGCTGGCGAACACCGGGCCCGAGACCAGGGAGTGGATCGCGGGACAGATGGAGCACCGCCGGCGGCTGGGGCCCCGTGAGCTGACGCTCCGCCGGGTCGCCGACGGGGTCGTGTGCCTCAACCCCCCGCAGAACGCCACGGTCGCCAACGCACTCCTCGGCATCTGGGTCCTCGCGGGCGGCAACTCCCTCGTCGTCCGGGCACCCCGCAGCGCACCGCTCGGCGTGATGCACGCCCTGCACGAACTGATCGTGCCGGCGCTCGAACGGGCCGGCGCACCCCCCGGGGTCCTCTCCGCGATCTGCTCCCCGGCCGGGCCCGCACTGGCCCAGTGGCTGGACAGCCCGCTGGTCGACGACATCATGTACTTCGGGGACAGCGAGAAGGGCATCGCCTTCGGCGCCGAGTGCGTGGCGCGGGGCAAGAAGCCGGTCCTGGAGCTCGCCGGCAACGACATCGTGGTCGTCTGGCGCGACGCGGACCTGGAGCGCGCGGCGGACGCGCTGGCGGAGGCGTTCTACGGCTCCGGGCAGATCTGCATGGTCCCCAACTGCGCCGTGGTGCACCCCGCCGTGGCCGACGAGCTGCTCGGCCTGCTCGCCGACCGGGCGAGGGCGATC	MRSYGTYVDGHERPSDKWVYTVHSSAMLRDTMGSVRLKRGLERGRIAPEAATDDVVGRVAVGDGHDMDAALHVAAGAARAWSAVPPAARLRVVEEFHHLVREKSAEIIDVMVAEGHPRMLARWEVAGMLANTGPETREWIAGQMEHRRRLGPRELTLRRVADGVVCLNPPQNATVANALLGIWVLAGGNSLVVRAPRSAPLGVMHALHELIVPALERAGAPPGVLSAICSPAGPALAQWLDSPLVDDIMYFGDSEKGIAFGAECVARGKKPVLELAGNDIVVVWRDADLERAADALAEAFYGSGQICMVPNCAVVHPAVADELLGLLADRARAI	MMMLSRWRRSAVVLRIAAALLSPLAVAIPAHADAIANAANAVAPKIVERADWGKYFDAEGAKGTIIVLDGRTGGYQAYDSTRANQRMSPASTYKIFNSLLALESGALDNEREIIPWDGKPRSMKRWNAAMNLRDAFRVSCLPCYQVVSRKIARTYAQGKLDAVGYGNHTIGSAADAYWVDNSLQISAREQVVFLQRLARGQLPFSARTQDIVRQISIAEANMDYVLHGKTGWYVDGKHDIGWWVGWIERDGNITTVALNMDMRSDADAPKRARIARAVLKDLKLI	117.19	gnl|BL_ORD_ID|2648|hsp_num:0	3421		
BGC0001382.1|Svaricin_2 # 1018 # 3855 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.732	BGC0001382.1|Svaricin_2 	1018	3855	-	Loose	750	27.7202	adeF	46.15	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGAGCTCGCACCCGAGCAGTCCCGGCGAGCCGGCCGGGGCACGCCCGTCGCCGTCGTCGGCATGGCCGGCCGCTTCCCCGGCGCGGACGACGTCGGCCAGTTCTGGCAGAACCTGCTCGACGGCCACGAGTCCGTGCGGGAGTTCACCGCCGACGAGATGCGCGCCGCCGGCGTACCGGAGGCGGGGATCTCCGATCCCAACCGCGTCCCCGCGGGTGCCGACATGGCCGGCGCGGACCTCTTCGACGAGCAGTTCTTCGGCATCACCGGACGTGACGCCGCCCTGATGGACCCGCAGCACCGAATCCTGCTGACCTGCGCCTGGGAGGCGCTCGAGGACGCGGGCACCCGCCCGGACTGGAGCGACGGCCGGATCGGCGTCTTCGCCGCCACGAGCCTGAGCACGTATCTGCTCTCCCAGGTCCTGCGGTCGGCCGACCACGCCGACGAGGCCATGAACTACCCGGTGCTGATCGGGAACGACAAGGACTTCCTCGCCACCCGGGTCGCCTACAAGCTCGGTCTGACCGGCCCGGGCATCAGCGTGGCGACGGCCTGCTCCAGCTCGCTCACCGCCGTGCACCTCGCCTGCACGGCACTGGAACGCGGCGACTGCGACGCTGCCCTCGTCGGCGGCGTCAGCATCACCGTGCCCCAGACCAGCGGCTACCTGTACCAGGAAGGCGGAATCCTCTCCCAGGACGGGCACTGCCGCGTCTTCGACGCCGCGTCCGGCGGCACGGTGAAGGGGAACGGCTGCGGAGTCGTCGTGCTCAAGCCGCTGGACAGGGCACTCGCCGAGGGAGACCGCGTCTACGCGGTGATCCGCGGCAGCGCGGTCAACAACGACGGCTCCGACAAGATCGGTTTCACCGCCCCGGGCCCCGCCGGGCAGCAGGCCGTCATCGAAGCGGCCCTGCGCGACTCCGGCGTGCCGGCGGACTCCATCGGGTACGTCGAGGCGCACGGCACGGGAACCGCGCTCGGCGACCCGCTGGAGCTGCGGGCGCTCGCCGCGGCGCACCGCGCCGCCGGCGGTCCGGCCCCCGACTGCGCCGTCGGCAGCCTCAAGGCCAACATCGGCCATCTCGACGCCGCCGCGGGCGTGGCCGGACTGATCAAGACGGCGCTGGTCCTGCACCACCAGACCGTCCCGCCGCAGATCAACTTCACCGCGCCCAATCCTCACATCGGTCTGGACGCACTCCCCTACCAGGTGCGCACCACTGCCGAGGGCCCTCCCCAACTGCCGCTGCGGGCCGCGGCCGTGAGCTCCTTCGGCCTGGGCGGTACGAACGCGCACTGCGTGCTGGAGGCCGCGCCCCGGCCACAGGACGCGGGGTCCGGGCCGACCGGCGTGCGCTACCCGGTCGTGCTCTCGGGGAAGGACGACCGCGGTCTGCGGGCCGTCGCGCGCCGGCTGCGGGACCACCTCGCGGCCGCGCGGCACCGCCCGACCGTGCGCGACCTCGCGTACACGCTGCTCGCAGGCCGGCAGCCGATGCCCGTGCGGCACGCGTTCGCCGCCGCGGACATCGACGAGGTACTGGCGGAGCTCGACGCGCTCCTGGACGAACGCGAGGACACCCGGGCGGCCGCGGACTCCGGCGTCACCGGGCAGGCCGTGCGGAGCTGGCTGGCCGGGCGGGACCTGCCCGCCGGCGAGTGGGCCGAGGCCTGGGACTTCCGCTCGGCACGCAAAGTCGCCTTGCCGGCCTACCCCTTCCAGCGCAACCGCCACTGGATCGAGGCGGCCCCGCCGACCGGTGGGGCGGTCACGGCCGACGAGTCCGTGGACGCGGGCTCGGGCACGGGAGTGACCAGGGAACAGTTCACCGCCCTGCTCGGGAAGCACCTCGGGGTGACCGGAATCGCCGAGGACGACGACTACTACGACCTCGGCGGGGACTCGATGCTCGCGGTCGAGATCGCCACCTCCCTGCGCGACGCGTTCGGCGTGCCGATCGACCTCGATGTCTTCGCGCAGCTGAGCACGGTGGGCGAACTGGCCGACTACGTCGTGTCCGTCGGCGCGGCCCCGGACGGTGCCCGGGACCGCATCGGGCGCGTCGTGCCGATCCGCCAGGGCGAGGGCCGGACGCTGTTCCTCGTCCACCCCGCGGGGGGCACCAACTTCGTCTACTTCCGGATGGCCGTCCACTCCCGCTCCGCCGAGCCCCTCGCCGCGGTGTCCTACCCCGGTGAGGAGGACGGGCGACCGGGCACGCTGCGGGAGCTGGCGGCGCTCTACGTCGAACAGATCCGGCGCGAGCAGCCCCACGGCCCCTACCGGCTCGGCGGCTACTCCTTCGGCGGCAACGTGCTGTTCGAGATGGCGCTCCAACTGCGGGCTGCGGGCGAGGAGGTCGACACGCTGCTGATGCTGGACAGCCACCCGCCGGAGGCGTACGTCGGCGGCCACATCGGCGACGACGAGTTCGAGCGCGCCGTTCCGCTGCTGCTCACGTCCGCCGCTGCCGACGAGGAGCAGATGGAGCTGCTGCGCCGCGAGGGCTTCGTCGCGGCCTGGCGGCACAACCACGATCTGCTCAAGGGCCACTACCCGGACCGGCGGTTCGACGGCGACATCGTGCTGGTGGTCGCCGAGGAGGACGAGGACGGCGCGCTCCTGGACACCATGCGCATCCGGCGCCTCGACAAGGCGTCCCTCTGGGGCGGTCACGTCGAGGGCCGGGTCGAGGTCCTGAAGACGCCCGGCGACCACTTCAGCATGTTCGAGGACGGCGGGCGGCTCGAAGCGCTCGCCGCGACCTTCGACCGCGCACTGGCACGGATAGCCGAAGCGGCCGGCGGAGACGGGGACCTGGGATGA	MTELAPEQSRRAGRGTPVAVVGMAGRFPGADDVGQFWQNLLDGHESVREFTADEMRAAGVPEAGISDPNRVPAGADMAGADLFDEQFFGITGRDAALMDPQHRILLTCAWEALEDAGTRPDWSDGRIGVFAATSLSTYLLSQVLRSADHADEAMNYPVLIGNDKDFLATRVAYKLGLTGPGISVATACSSSLTAVHLACTALERGDCDAALVGGVSITVPQTSGYLYQEGGILSQDGHCRVFDAASGGTVKGNGCGVVVLKPLDRALAEGDRVYAVIRGSAVNNDGSDKIGFTAPGPAGQQAVIEAALRDSGVPADSIGYVEAHGTGTALGDPLELRALAAAHRAAGGPAPDCAVGSLKANIGHLDAAAGVAGLIKTALVLHHQTVPPQINFTAPNPHIGLDALPYQVRTTAEGPPQLPLRAAAVSSFGLGGTNAHCVLEAAPRPQDAGSGPTGVRYPVVLSGKDDRGLRAVARRLRDHLAAARHRPTVRDLAYTLLAGRQPMPVRHAFAAADIDEVLAELDALLDEREDTRAAADSGVTGQAVRSWLAGRDLPAGEWAEAWDFRSARKVALPAYPFQRNRHWIEAAPPTGGAVTADESVDAGSGTGVTREQFTALLGKHLGVTGIAEDDDYYDLGGDSMLAVEIATSLRDAFGVPIDLDVFAQLSTVGELADYVVSVGAAPDGARDRIGRVVPIRQGEGRTLFLVHPAGGTNFVYFRMAVHSRSAEPLAAVSYPGEEDGRPGTLRELAALYVEQIRREQPHGPYRLGGYSFGGNVLFEMALQLRAAGEEVDTLLMLDSHPPEAYVGGHIGDDEFERAVPLLLTSAAADEEQMELLRREGFVAAWRHNHDLLKGHYPDRRFDGDIVLVVAEEDEDGALLDTMRIRRLDKASLWGGHVEGRVEVLKTPGDHFSMFEDGGRLEALAATFDRALARIAEAAGGDGDLG	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	89.24	gnl|BL_ORD_ID|137|hsp_num:0	153		
BGC0001382.1|Svaricin_3 # 3852 # 7052 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0001382.1|Svaricin_3 	3852	7052	-	Loose	400	27.335	CatU	41.18	3003983	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGAGGGCACACGAAAGCACTTTTGGGGGAAGCATGGGAAGCCAAGAGAGCGTGACGCCGGCGACCCCGGCGCAGCTCAAGCTCTACACACACGCAAGGGTGTTCCCCAGAGACCCGTCGTTCAACCTGGGTGGCACCTTCCACATCACGGGTCCGGTCGACGTCGACCGGCTGAGGACGGTCATCGGGCGGCTGGGGGCGGGAATCCGCGCGCTCAACACCTCATTCGAGGAGCGCGGCGGCACCGTGTACGCAGTCCACCGCGTCCCCGACGTCGCCGACCCGGCCGACCTGGTGACGGTGACCGAACTCCACGGCGAGGGCTTACACGAGGCACCCCGGCGGTTCGCCGCCAAGGCCGACCGCCCCATCCCTCCCGAGGCACCCCGCCAGTACGACTTCGAGATCTTCCGGGCGCCGGACGGAGTGTTCGTCACACTGCTGTTCTCGCACCTGATCTGCGACGCCTACACCTTCTACATGTTCGTCACCGAGCTGGAGCGCCTGTACGCCGACCCGGAGGCCGAACTGACCCCGGCAGCCCTGGACGAGCCCGGCTCGCTCGTCACCGGTGCCGCACCCGCGTCGCCCGCCGCCGTCGACTTCTTCCGCAAGCGGCTCGGTGGGGTGACGACGTTCTCCGACGACCGCCTCCAGGGCAGCCGTGCGGCCGGCGGCGCCCTGCGGGGGCACCAGCGTCACCTCGTCCTCACCGAGGAGGAGAGCGACCGGATCCGTACCAGGGCCGAGGACATCGGTGTCAGTCCCTTCGCCTTCTTCCTCGGGGCGTACCTCCTCGTCCACGCCCGCGTCACCGGCCGGCGCGAGGTCGTCACCGGCCTCCCCCTGGCGAACCGCCGGGGCATCCGCCAGCGCAAGGCGTCCGGATACTTCGTCAACATCCTTCCCCTCGCGGTGGACCTGTCCGGCTACGGCAGCTTCGGCGAGCTGTGCCGGGACGTGCAGGAGACCACGCTCGGAATGCTCCGCTACCAGGGCTTCGACGTGGCCGCCCAGGTCCGGGAGGTGTGCCCCGGTGCCGAGGGCGGCTCCCTCGCGTTCAACAGCGCCTTCACCTACTACAAGCAGCCCCTGCAGATCCGGATCCCGGGCTGCACCATCGAGTCGATCGAACTGCCGCGCCGGTACGCCAAGTACCCCCTCGTCATGAACGTCGAGGACTTCGGTACCAGCTTCAACGTCAACGTCGAGTGCTCCGAGGAGCAGTGGAACACCGACCCGCTCGCCTGCATGCGGCAGGTCCTGGAAACGGTGTCCGCCGCCGGTGCGGACGTGCCCCTGCGCGACATCCCCGCGATGCCCCCGGAGGCGGAGAGGGAGCTGTCCCGGCGCATCAACCCCGGCGCTCGCGTCGTGGACGACGGCCCGTTCCCGTCCCTGACGACGTGGTTCTCGGACGTGGCACGGACCCATGCCGAGCGCGTCGCCGTGCGCGACGGCGACGAGTCCGTCACCTACGCCGAACTGGACGCCCGTGCCGACCGGGTGGCCCACGCCCTCGGCCGCGAGGTACCGGGCGAACACGTCGGTGTGGCCATGCGGCGCGGGTCCGACCTGCTCGCCGTGATCCTCGGTGTGCTCAAGGCGGGCAAGGCGTACGTGCCGCTCGACCCGGGATCGCCCGCGAGCCGTGTCGGCCGGATCCTGGAGAGCTTCCCCGGCGGTCTCCCCGTCGTCGCCGACGAGGAGCGCTGGCCGGACGGGGCGGTGCGCCACCTCGACGCCGCGGCTCTGCTCGTGCCCGGGGAACCGGTTCCCGCACCGGAGCCGGTGAAGGACCCGGACGCCTGCGCGTACACCATCTTCACCTCCGGCTCGACCGGGCGCCCCAAGGGTGTCCAGGTCACGCACAGGAACGTCGTCCGCCTCTTCCGGGCCTGCGAGGAGCACTTCGACTTCGGTCCCGACGACGTCTGGAGCCTGTTCCACTCCTACGCGTTCGACTTCTCGGTCTGGGAGATCTTCGGCGCCCTGCTGTACGGCGGCCAGGTGGCCGTGGTGCCGGCGGACACGGCCCGTTCACCCCAGCAGTTCCGCGACTTCCTCGCCGAGTACGGCGTGACCGTGCTCAACCAGACCCCCTCCGCCTTCGGCCAGCTGCTGAAGGTGCTGCGGCCGGGCGACCGGACCGCACTCGACGTCCGGTACGTCGTCTTCGGCGGCGAGCCCCTCCGCTACGCCGCCCTGCGCCCCTGGTACGAGCTGATGGGCGAGCAGGCACGGCTGGTCAACATGTACGGGATCACCGAGACCACCGTGCACGTCACCCACCACGCGGTCACTCCCGCGGACGCCCTCATGGAGAAGTCCTCGCTGATCGGCAGGCCCCTGGCCGATCTCACCGTCAGCGTCGTCGACGGCGAGGGCCGGCACTGCCCGCCCGGCGTACCCGGAGAACTCGTCGTGTCCGGGCCGGGTGTGACGCTCGGCTACCTCGGCAGGCCCGACCTGACGTCCGAGCGCTTCGTCGTCGCGGACGGAGTCACGGCGTACCGCAGCGGCGATCTCGGTCTGGCCCGGCCGGACGGATCTCTCGTGCACCTGGGCCGCATCGACACCCAGGTCCAGTTGCGCGGCTTCCGCATCGAGCTCGGTGAGGTCGAGTCGGCGCTGCTGTCCGTCGACGGCGTGCGCGAAGCCGCGGTCCGGCTCGACGACCGCGACCCGGAGCATCCGTCCCTCGTCGCCTTCGTCGTGGACTCGGCTGCGGTGCCGGACGACCGGACCCTGCTGCGGCTGCTGCGCGAACGGCTCCCCGCGTACATGGTTCCCGCCAGGACGGTGCGGCTGACGGCCCTGCCGCTGACCGTGAACGGCAAGGTCGACGACTCCGCGCTGCCCTGGCCCTCCCTCGGCGACGCCGTACCGGCCCCCCTCGAGCGCACGCCGACCGGTCGCACCACCACCGACCTGGTGCTCTCCGTGTGGAGTGACGTCCTGCCCGGCGTGAGCGTGGGCGAGGACGACAACTTCTTCGACATCGGAGGCTCCTCGATGCACGTGGCCGACGTGCACACGAGGCTCCAGGAACAACTCCCGGGAGTTCCCCTCGACATGATCGCCCTGTTCACGCACACCACGGTGCGCAGACTGGCCGCGCACATCGACACCCTCGGAGCGGACGGGAAAGCCCCCGGTGCCGCCGGCTCCCCCGCTGCCCAGGAAGGGGCGACCCAGTGA	MRAHESTFGGSMGSQESVTPATPAQLKLYTHARVFPRDPSFNLGGTFHITGPVDVDRLRTVIGRLGAGIRALNTSFEERGGTVYAVHRVPDVADPADLVTVTELHGEGLHEAPRRFAAKADRPIPPEAPRQYDFEIFRAPDGVFVTLLFSHLICDAYTFYMFVTELERLYADPEAELTPAALDEPGSLVTGAAPASPAAVDFFRKRLGGVTTFSDDRLQGSRAAGGALRGHQRHLVLTEEESDRIRTRAEDIGVSPFAFFLGAYLLVHARVTGRREVVTGLPLANRRGIRQRKASGYFVNILPLAVDLSGYGSFGELCRDVQETTLGMLRYQGFDVAAQVREVCPGAEGGSLAFNSAFTYYKQPLQIRIPGCTIESIELPRRYAKYPLVMNVEDFGTSFNVNVECSEEQWNTDPLACMRQVLETVSAAGADVPLRDIPAMPPEAERELSRRINPGARVVDDGPFPSLTTWFSDVARTHAERVAVRDGDESVTYAELDARADRVAHALGREVPGEHVGVAMRRGSDLLAVILGVLKAGKAYVPLDPGSPASRVGRILESFPGGLPVVADEERWPDGAVRHLDAAALLVPGEPVPAPEPVKDPDACAYTIFTSGSTGRPKGVQVTHRNVVRLFRACEEHFDFGPDDVWSLFHSYAFDFSVWEIFGALLYGGQVAVVPADTARSPQQFRDFLAEYGVTVLNQTPSAFGQLLKVLRPGDRTALDVRYVVFGGEPLRYAALRPWYELMGEQARLVNMYGITETTVHVTHHAVTPADALMEKSSLIGRPLADLTVSVVDGEGRHCPPGVPGELVVSGPGVTLGYLGRPDLTSERFVVADGVTAYRSGDLGLARPDGSLVHLGRIDTQVQLRGFRIELGEVESALLSVDGVREAAVRLDDRDPEHPSLVAFVVDSAAVPDDRTLLRLLRERLPAYMVPARTVRLTALPLTVNGKVDDSALPWPSLGDAVPAPLERTPTGRTTTDLVLSVWSDVLPGVSVGEDDNFFDIGGSSMHVADVHTRLQEQLPGVPLDMIALFTHTTVRRLAAHIDTLGADGKAPGAAGSPAAQEGATQ	MKFHIINVEEWTRKPYYEHYLRSNKCTFSITVDIDITRLLYSLKANGFKLYPAFIYMVTRVVNDRVEFKTSFSPEGELGYWDRMTPSYTFFHNDDHTFSCLWTAFSNDFYRFHDHYEQDMEQYRDTKGLFVKENPPPNTFPISMIPWTSFSGFNLNIVNEADYLLPIITGGKYTEQGGRVLLPVSLQVHHAVCDGYHASMFFKELQSLADSFEDWLT	491.24	gnl|BL_ORD_ID|2290|hsp_num:0	2520		
BGC0001382.1|Svaricin_4 # 7049 # 7831 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.727	BGC0001382.1|Svaricin_4 	7049	7831	-	Loose	800	25.409	adeI	44.44	3000780	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCACCGCACTCATCACCGGAGCAACCGCCGGGCTCGGCCGCGCCTTCGCCCAGGCCCTCGCCCGCGACGGATACGGCCTGGTCCTGGTCGCCCGGTCCGAACCCGCGCTCAGGAAGACGGCCGAAGAGCTGCGGGACGCCCACGGCACGGCGGCCGAGGTGCTCGCGGCCGACCTCGCCACCGACGAGGGCTGCGACGCGGTCCGTGCCCGCCTCGTCTCCGGGCCGCGGGTGGATCTGCTCGTCAACAACGCGGGCATCGGACACGAACGCCCCTTCCTGACGAACGGCACCGCCTCGGAAGAACGACTCCTCGACCTCAACGTAAGGGCCGTGCTGCGCCTCACCGACGCGGCACTGACCGCCATGACCGACCGCCGCGGGGGCGCGATCCTCAACGTCGCCAGCGTCGCCGGCGTCGGGCCGTCGTGGCTGAGCTCCACCTATCCGGCGAGCAAGGCGTGGGTGATCGCCTTCACCGAGTCCCTGGCGTGGTCCCGCCAGGTGCGCGAGGCCGGCGTCCGCATGACCGCGGTCCTCCCCGGATACACCCGCACCGAGTTCCACCAGCGCGCCGGCATCCCGACGACGTTCCCGCCGGCCTGGCTGTGGCTGGACGCCGACGACGTGGTGCGCACCGCGCTCCGTGACCTGCACAGGGGAAAGGTCATCAGCGTGCCCAGCCTTCGCTACAAGGCCGCCGCCTGGATGCTGCGGCACCTGCCGCGATCGCTGACGCGCCAGGGCGCCTGGGACATCAGCGCCCATCCGCACCGATGA	MPTALITGATAGLGRAFAQALARDGYGLVLVARSEPALRKTAEELRDAHGTAAEVLAADLATDEGCDAVRARLVSGPRVDLLVNNAGIGHERPFLTNGTASEERLLDLNVRAVLRLTDAALTAMTDRRGGAILNVASVAGVGPSWLSSTYPASKAWVIAFTESLAWSRQVREAGVRMTAVLPGYTRTEFHQRAGIPTTFPPAWLWLDADDVVRTALRDLHRGKVISVPSLRYKAAAWMLRHLPRSLTRQGAWDISAHPHR	MMSAKLWAPALTACALATSIALVGCSKGSDEKQQAAAAQKMPPAEVGVIVAQPQSVEQSVELSGRTSAYQISEVRPQTSGVILKRLFAEGSYVREGQALYELDSRTNRATLENAKASLLQQQANLASLRTKLNRYKQLVSSNAVSKQEYDDLLGQVNVAEAQVAAAKAQVTNANVDLGYSTIRSPISGQSGRSSVTAGALVTANQTDPLVTIQQLDPIYVDINQSSAELLRLRQQLSKGSLNNSNNTKVKLKLEDGSTYPIEGQLAFSDASVNQDTGTITLRAVFSNPNHLLLPGMYTTAQIVQGVVPNAYLIPQAAITRLPTGQAVAMLVNAKGVVESRPVETSGVQGQNWIVTNGLKAGDKVIVDGVAKVKEGQEVSAKPYQAQPANSQGAAPNAAKPAQSGKPQAEQKAASNA	62.50	gnl|BL_ORD_ID|1385|hsp_num:0	1471		
BGC0001382.1|Svaricin_5 # 7861 # 9048 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.705	BGC0001382.1|Svaricin_5 	7861	9048	-	Loose	400	29.6462	Pseudomonas aeruginosa CpxR	28.99	3004054	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGGCGTCATTGAAAAGTGCTATTCCTACACCCGTTCCCGGGAAGGGAAAGCAAGCGGCTACTACCCCTTCTTTGTCAGTTTCGACGGCCGCACCGACGGGGTGGCGCGGCTCTCCGACGGCCGCGAACTCGTGATGTGCGGCTCCAACGACTATCTGGGACTGAGCACCGATCCCCGCGTGACGGGTGCCGCGGCCGAGGCCGCACGCGACCTCGGCGCCGGATGCACGGGGTCCCGCCTGCTCAACGGCAACCTCGAACTGCACGAACGACTGGAGCGCGAGCTCGCCGCCTTCTTCGGCAAGGAGGCGGCCCTGGTCCTCACCACCGGGTACCAGGCCAACCTGGGTGCCGTCGCGGGGCTGTGCGGTCCCGGGGACACCGTGTTCGTCGACCGGGACGCCCACGCCTCGCTCATCGACGCGGTCCGGCTCAGCCGTGCCAGGCTGCAGTGGTTCGACCACAACGACACGGCCGACCTGGCGGCGAAGCTGGCCCGGCATCCGGGCCGCGGCGGCCGACTCGTCGCCGTCGACGGCGTCTACAGCATGGAGGGCGACCTCTGCCCGCTGCCCGAACTGGTGCGGGTCTGCGAGGAGTCCGACGCCACGCTGCTCGTCGACGACGCGCACGGCGCGGGAGTCCTCAGCGCCGGCCGCGGCACCTGCGACCACTTCGGCCTGACCGACAGGGTGCCCCTCATCACCCTGACCTTCTCGAAGGCCTTCGGCTCCATCGGCGGAGCGGTCCTCGGTGACGAGGCCGTCATCGAGTACCTCCGTCACCACGCCCGCAGCCTGCTCTTCTCCGCCAGCAGCAGTCCGGCCAACACCGCTGCGGCGCTGGCGGCGCTCGACATCGTCCGTGACGAGCCCTGGCGCTGCGAGACCGTGGTGAAGAAGGCGGACTACATGCGGCGGGAACTGGCCGCGCTCGGCTACCGCACGGGCAACTCCGAGTCCCCCGTCGTCCCCGTCGACACCCACGACGAACTGCACACCGTCGTCGGGTGGAAGCGCCTGATGGAGGAGGGTGTGTACGTCAACGCCGTCCTGCCACCCGCCGCGTCGCCCCGGCTGCGGACCAGCTACACCGCCGTCCAGACCGACGAGCACCTCGAGCGGACGCTCGCCGCCTTCGCGACCGTGCGGAGCGACCTCGGCCCCGTGCTGACAGACGCCGCGTGA	MGVIEKCYSYTRSREGKASGYYPFFVSFDGRTDGVARLSDGRELVMCGSNDYLGLSTDPRVTGAAAEAARDLGAGCTGSRLLNGNLELHERLERELAAFFGKEAALVLTTGYQANLGAVAGLCGPGDTVFVDRDAHASLIDAVRLSRARLQWFDHNDTADLAAKLARHPGRGGRLVAVDGVYSMEGDLCPLPELVRVCEESDATLLVDDAHGAGVLSAGRGTCDHFGLTDRVPLITLTFSKAFGSIGGAVLGDEAVIEYLRHHARSLLFSASSSPANTAAALAALDIVRDEPWRCETVVKKADYMRRELAALGYRTGNSESPVVPVDTHDELHTVVGWKRLMEEGVYVNAVLPPAASPRLRTSYTAVQTDEHLERTLAAFATVRSDLGPVLTDAA	MSELLLIDDDRELCELLGTWLVQEGFSVRASHDGAQARRALAEQTPDAVVLDVMLPDGSGLELLKQLRGDHPDLPVLMLSARGEPLDRILGLELGADDYLAKPCDPRELTARLRAVLRRTHPAQPSAQMQLGDLSLNLTRGVAQIDGQEISLTLSESRILEALLRQPGEPLDKQALAQLALGRKLTLYDRSLDMHVSNLRKKLGSHPDGSPRILALRGRGYYYSH	175.56	gnl|BL_ORD_ID|2362|hsp_num:0	2685		
BGC0001382.1|Svaricin_6 # 9078 # 9341 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.629	BGC0001382.1|Svaricin_6 	9078	9341	+	Loose	500	23.483	OXA-12	34.48	3001407	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCGGTACGGAAATCTTCACCGGCGATTTCTATTTCCGAGCAGCCTCGAGCCGGCAATCGGCCGGCAGGCACACACGGCACCGCGTACCTGAAGACGGCGGCGTCCGGTGAGAAAGAGAAGAAGAAAGTAAGATTGCTCAGGCGCGTGAGCGCGCCAAGGCGATGGCCTCGTGCATGTGTACTCCCCCGTACGTTTGCAGACCGGCACTGGCTGGGCACGGACCGAGCCCCAGGCCTGTCAGCAGCAGAGTCCCCCTGGTGA	MAVRKSSPAISISEQPRAGNRPAGTHGTAYLKTAASGEKEKKKVRLLRRVSAPRRWPRACVLPRTFADRHWLGTDRAPGLSAAESPW	MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVNEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYTANILKVSEVEGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASIKAKEEVLAALPAQLKKL	32.95	gnl|BL_ORD_ID|172|hsp_num:0	186		
BGC0001382.1|Svaricin_7 # 9712 # 10419 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.727	BGC0001382.1|Svaricin_7 	9712	10419	+	Loose	450	46.9802	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	24.62	3004045	protein variant model	F203L	n/a	isoniazid; triclosan	antibiotic target alteration	antibiotic resistant fabI	ATGTCCGGACGCACCGCCCTCGTCAGCGGGGGGAACCGGGGGATCGGTCTCGCCGTGGCCCGGGCACTGCACGCCGGCGGCGACTCGGTCGCCGTCACCTGCCGGAGCTCCCCACCGCCCGACGACTTCCTGGCGGTCAAGTGCGACGTCACCTCGAAGCAGGAGGTGGACGACGCCGTCGGCCAGGTCGAGGAGACGCTCGGCCCCGTCGAGGTGCTGGTGGCCAACGCCGGCATCACCCGCGACGCGCTGCTGGTCGGCATGGGCGAGGACGACTTCCTCGACGTGGTCGACACCAACCTGATGGGTGCCGTGCGCCTGGTCCGCCGCACCCTGCGCGGCATGGTCCGCCGCCGCCACGGCCGCATCGTGCTGATCTCCTCCACCTCCGCCCTCTCCGGCTCGTCCGGCCAGACCAACTACGCCGCGGCGAAGGCGGGGATGGTCGGGTTCGCCCGATCCCTGGCCCGCGAACTCGGCCGCCGGGACATCACGGTCAACGTGGTCGCGCCGGGCTGGATCGACACCGACATGACCGCCGCGCTGCCGGAGGAACTGCGCAAGGAGGCCGCCGGGACGGTGCCGCTCGGGCGCTTCGGCACCCCGGAGGACGTCGCCGCCACCGTGCGGTTCCTGACCAGCCGGGAAGCGGGCTACATCACCGGAGCCGTCGTGCCCGTCGACGGCGGAATCGGAATGGGGAACTGA	MSGRTALVSGGNRGIGLAVARALHAGGDSVAVTCRSSPPPDDFLAVKCDVTSKQEVDDAVGQVEETLGPVEVLVANAGITRDALLVGMGEDDFLDVVDTNLMGAVRLVRRTLRGMVRRRHGRIVLISSTSALSGSSGQTNYAAAKAGMVGFARSLARELGRRDITVNVVAPGWIDTDMTAALPEELRKEAAGTVPLGRFGTPEDVAATVRFLTSREAGYITGAVVPVDGGIGMGN	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	89.69	gnl|BL_ORD_ID|2390|hsp_num:0	2666		
BGC0001382.1|Svaricin_8 # 10419 # 11234 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.725	BGC0001382.1|Svaricin_8 	10419	11234	+	Loose	450	122.479	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	32.44	3004045	protein variant model	G93A	n/a	isoniazid; triclosan	antibiotic target alteration	antibiotic resistant fabI	ATGGGACTGCTCAACGGAAAGACCCTGCTGGTCACGGGGGTCATCACCGACTCCTCGATCGCCTTCCACGCCGCCCGGGCGGCGCAGGAGCAGGGCGCACGCGTCGTCCTCACCGGCTACGGACGGCTCAGCCTCGTCCAGCGCATCGCCAGGCGGCTGCCCGAGCCCGCCCCGGTGATCGAGCTGGACGTGACCGACGCGGAACAACTGGCCTCGCTGGCCGACCGCGTGCGCCCGCACGCCGACCGGATCGACGGCGTGCTGCACTCGGTCGCCTTCGCCCCGCCCGGGGCGCTCGACGGCAACTTCCTCACCACGTCGTGGGACGAGGCCGCCACCACGTTCCGGATCTCCACCTACTCGCTCCAGGCGCTCACCAGCGCCGTGCTGCCCCTCATGGACCGCGGCGGATCGGTCGTCGGGCTCGATTTCGACGCGTCCTCCGCGTGGTCCGGCTACGACTGGATGGGTGTGGCGAAAGCCGGCCTCGAGTCGTGCACCCGCTATCTGGCGTCGCACCTCGGCGCACGCGGCATCCGGGTCAACCTCGTGGCGGCGGGGCCCCTGTTGACGATGGCCGCACGGAACATCTCGCCCACCGCCGAGTCCGAGGGCGCCGCGCCGTTCGGCTCGGAGTGGTCGGAGCGCTCACCCCTCGGCTGGGACCCGTCCGACTTCGAACCGGTCGCCCGCGCGTGCGTCGCGCTGCTCTCCGATCTCTTCCCGGCGACCACCGGCGAGATCGTGCACGTCGACGGCGGGGCGCACGCCATCGGGGATCGCCCTGCGCGCCTCGCGGCGGAGGTGGCGGGATGA	MGLLNGKTLLVTGVITDSSIAFHAARAAQEQGARVVLTGYGRLSLVQRIARRLPEPAPVIELDVTDAEQLASLADRVRPHADRIDGVLHSVAFAPPGALDGNFLTTSWDEAATTFRISTYSLQALTSAVLPLMDRGGSVVGLDFDASSAWSGYDWMGVAKAGLESCTRYLASHLGARGIRVNLVAAGPLLTMAARNISPTAESEGAAPFGSEWSERSPLGWDPSDFEPVARACVALLSDLFPATTGEIVHVDGGAHAIGDRPARLAAEVAG	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	103.44	gnl|BL_ORD_ID|2390|hsp_num:0	2666		
BGC0001382.1|Svaricin_10 # 11800 # 12048 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.639	BGC0001382.1|Svaricin_10 	11800	12048	+	Loose	550	22.3274	CAU-1	38.46	3000855	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	CAU beta-lactamase	ATGGCACTCGACCTGAACGAGATCCTCACCGGCCTCAGCGAGATCGTGAACGAGGTGACCGGCACCCCGATCGAGGACATCCAGCCCGACAAGTCGTTCGTCGACGAGCTGGACGTGGACTCGCTGTCCATGGTGGAGGTCATCGTCTCCGCCGAGGAGCGCTTCGACATCCGCATCCCGGAGGAGGAGGCCAAGACCTTCAAGACCGTCCGGGACGCGGCCGACTTCATCCTGCTGCACGCAGGCTGA	MALDLNEILTGLSEIVNEVTGTPIEDIQPDKSFVDELDVDSLSMVEVIVSAEERFDIRIPEEEAKTFKTVRDAADFILLHAG	MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVVLDGGPNAETGKLVERNITALGFQLADVKILINTHAHYDHAGGLAQLKADTGAKLWISRDDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWTTAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQGNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPNR	28.37	gnl|BL_ORD_ID|1041|hsp_num:0	1109		
BGC0001382.1|Svaricin_11 # 12124 # 12822 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.725	BGC0001382.1|Svaricin_11 	12124	12822	-	Loose	1200	25.7942	tet(44)	28.57	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGTGGAAGCCGCACGCCCGCCTGCTGGCCCCTGATTTCAGGGTCACCGCATGTGATCTTCCGGGGCACGGCACCCTCGCCGCCTCACGGTTCACCCTCGACGGAGCGGTGGCCCAGGTCCGGGCCGCCCTTCAGGAGGCCGCGACCGCCACCGGCCGTCCGGTGGTCCTGGCCGGCATGTCACTCGGGGGCTTCGCGGCGCTCGCCACGACCGCCGCCCATCCGGAGCTGGTTGCCGGACTGCTCCTGAACAACTCGACCGCCCAGCCGCGCGGAGTGGCCGCCCGGCTCTACCGCAACGCAGGCCGGCTCATGCGCTGGGCCGGCGAGGAGCGGGCGGCACGGCTGAACGCCGCGCTCTTCAGGAAGTTGCTGCCCAAGGAGAGCGCCGAGGCGGTGCTGGCCGGCGGGCTCTCCATGCGGGGCTTCTCGGAAGCGGTGGACGAACTGCCGCGCCACGACTTCATCGCCATGGCCCGCCGGTGCACGGTTCCTCTCCAGATCGTGAACTGCCGGGGCGACCGGCTGCTCACGGCCGACGAGCGCGCGTTCCTGGAGGCCGCCCGCAGCGCGGGCTCGGCCGCCGAGCTGACGCACGTCAAGGGCACGCACATTCTGGCGTTGACCGACCCCGAGGGCTTCACCCGCATCCTGCGGTCCGGTTACGACCGGCTGACCGGAGGGGCGGCGAAGGCCTGA	MWKPHARLLAPDFRVTACDLPGHGTLAASRFTLDGAVAQVRAALQEAATATGRPVVLAGMSLGGFAALATTAAHPELVAGLLLNNSTAQPRGVAARLYRNAGRLMRWAGEERAARLNAALFRKLLPKESAEAVLAGGLSMRGFSEAVDELPRHDFIAMARRCTVPLQIVNCRGDRLLTADERAFLEAARSAGSAAELTHVKGTHILALTDPEGFTRILRSGYDRLTGGAAKA	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	36.25	gnl|BL_ORD_ID|1106|hsp_num:0	1171		
BGC0001382.1|Svaricin_13 # 13337 # 14776 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.700	BGC0001382.1|Svaricin_13 	13337	14776	+	Loose	1650	30.0314	Listeria monocytogenes mprF	26.39	3003770	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGACGTCAAAGCTATTCACTCCGCATTCGGAAACGACCTACGACGAAGTCGAACGCCAGGCGCTCGGCCTGGCGGAGGCGCTGCGGGCGCGTGGCATCGAAGCCGGTGACCGCGTCACTCTCAAGGCGGGCAATTCGGGCGGTTTCGTCGTCGTCCTCCTCGCCCTGATGCACACCGGGGTCTCGATCGTGCTCCTCGACGACCTCCAGCAGGACGCCGTCACCGAGCGGGTCGTGACCCTGGCCCGCTCCCGGCTGACCATCACCGACGGCACGAACCGGCCACCGGCCGGTGCGACGGTCTCCGTGGACGAGCTCCTCGCCGAGGCGGCCGGCGGCCCCTCCACCACGAGCCATGAGGCGGGGGAGCTCTCCTTCACCGCCTGGCGCGCGCTCCCGGACGGCCTCATCACCTGGTCCTCGGGGTCGACGGGCGAGCCCAAGGGCATCGTCAAGTCCGGCGAGGCCATGCTCCGGAACCTCGACCGCTCCATCGAGCGGATGGGGCACCGCCCGGACGACGTGCTCCTGCCGCTGCTCCCCTTCTCCCACCAGTACGGACTGTCCATGCTGCTCACCGCGTGGCTGGCCCGCTCCTCCCTGGTCGTCGCACCGTACCGGCGGCTGGACCACGCGGTGCGCATGGCAGGCATGTTTGGTGCCACCGTGGTCGACGCCACTCCGGCGGTGCACCTCAGCATCCTCAACCTCGCGGAACGTCGGCCCGAGATGGCGGCGGACCTGCGCAAGGTGCGGATGTACTGCACGGGCGGCGCCCCGCTCGACCGATCCGCGGCCGAACGGTTCGTCGCCGCCTTCGGCCTGCCGCTGCTCGACGGCTACGGCAGCACCGAACTGGGGAACATCGCCTTCGCCACTCCGGACAACCCGGTGGGCTGCGGTCCCGTACTCCCCGGCATCGACGTGCGGCTGGAGTCCGGCCCCGGCGCGGAGGCCCCCGGCATCGGGGAGGTGATGGTCCGCACTCCGGACCTCTTCTCCGGCTATCTGGGCGCGGACGGGCAGGTGGACCCGGTCTCCGGCGACTGGTACCGCACGGGCGACCTGGGGCGCTTCGACGACGAAGGCAACCTGTTCGTCCTCGGCCGCAAGCTCGCCGTCCACCGCATGGGCTACACGCTCTACCCGGAGGTCATCGAGCGCACAGCCGGCGGCTGTGGAGCACCGGTCAAGATCGTCCCGCTGCCCGACGAACGACTCGGCAGCCGGCTGGTGTTCTTCGTCCAGGACCCCGAGGGCCGGGACGTCCTGTACTGGCGCGAGCGCATCTGCGCCCAGCTCTCGCCCTTCGAATACCCCAACCGCGTCGTGGTCTGCGGCGCCTTCCCGCTCAACCGCAACGGAAAGCCGGACAACAAGCAGCTCAGGGCCATGGCACTGGCCGGATCAGAAACACCCGAGGATCGGAGTTCACTCTAG	MTSKLFTPHSETTYDEVERQALGLAEALRARGIEAGDRVTLKAGNSGGFVVVLLALMHTGVSIVLLDDLQQDAVTERVVTLARSRLTITDGTNRPPAGATVSVDELLAEAAGGPSTTSHEAGELSFTAWRALPDGLITWSSGSTGEPKGIVKSGEAMLRNLDRSIERMGHRPDDVLLPLLPFSHQYGLSMLLTAWLARSSLVVAPYRRLDHAVRMAGMFGATVVDATPAVHLSILNLAERRPEMAADLRKVRMYCTGGAPLDRSAAERFVAAFGLPLLDGYGSTELGNIAFATPDNPVGCGPVLPGIDVRLESGPGAEAPGIGEVMVRTPDLFSGYLGADGQVDPVSGDWYRTGDLGRFDDEGNLFVLGRKLAVHRMGYTLYPEVIERTAGGCGAPVKIVPLPDERLGSRLVFFVQDPEGRDVLYWRERICAQLSPFEYPNRVVVCGAFPLNRNGKPDNKQLRAMALAGSETPEDRSSL	MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRASFYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYFPILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPDYLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVSHTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEIIEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASMMPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE	55.38	gnl|BL_ORD_ID|2108|hsp_num:0	2279		
BGC0001382.1|Svaricin_14 # 14776 # 16053 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.702	BGC0001382.1|Svaricin_14 	14776	16053	+	Loose	2030	28.1054	ceoB	30.14	3003010	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGCGCACACGAAACCCGACCGCTCAGGCGGGTGGTCGTCACAGGAACCGGTGTCATCACACCGATCGGCAACACCGTCGAATCGTTCTGGCAGTCCCTGATCGACGGCCGGAGCGGCATCTCCGCCATCGAGTCCTGGGACGCCTCGGACCTGCCGGTCCGTATCGGCGCCGAGGTCAAGGACTTCGACCCCGCGGCCTACATGCCGCACAAGGTGAGCCGCCGCATGGACCCCAGCGCCCAGTACGGGCTGGCGGCCGCCATGGAAGCGGTCCGGGAGGCCAAGCTCGAGATGAGCGACGACCTCGCCGCCCGCACCGGTGTCTATCTGGGCTCGTCCGTGGGCGCCGCCCAGATGACCTACGACACCACGGTCAAGCTCCACGAGCGGGGCGCCCGGGCGGTCAGCCCGTTCTTCTTCGCCACCAGCGGATCGGAGAGCGCCGCGGGCGAGGTCGCCATGTGGCTGGGCGCGCGCGGTCCTTCGTCGAGTCTGAGCACGGCATGCGCCTCCGGGGCGACCTGCATAGGCGAAGCGGCCCGGCTCATCCAGTTCGGGGTGACGGACGTCATGATCGCGGGCGGTGCGGAGGCGCCCGTGACCAGGCTGAACATCGCGGGGGCCGCCGCCTGCCAGGCGCTGTCCCGCCGCAACGACGACCCGTCGCTGGCCTGCCGCCCGTTCGACCGCGAGCGCGACGGCTTCGTCATGGGCGCCGGCGCCGGCGTCGTCGTCCTGGAGGAGTACGAGCACGCGCTGCGCCGCGGTGCGCACATCCTCGGTGAGCTGGCCGGCTACGGCGCCACCACCGACGCGTACCACCTGACCGCCCCCCATCCCGATGCGCTGGGCACCAAGACGGCGATGCGCATCGCGCTCGAGTCGGCGGGCCTGCAGCCGCAGGACGTCGACTACATCAACGCCCACGGCACGAGCACCCAACTCAACGACTCCACCGAGGTGTCCGCCATCCGCGGGGTGTTCGGCGAGCACGCCACGCGCATCCCCGTCAGCTCCACCAAGTCCATGACGGGACACCTCATTTCCGCCACCGGCGCCGTGGAACTCATCGCCGCGCTGCTGGCCGTCCGCCGCGACGTCGTCCCTCCCACCCTCAACTGCAACGACCCGCTGGACCCCGACATCAACTTCGTCCCGGGCGTGGCCCAGGAGTGGGAGGTCGATGTCGCCATGAGCAACTCGTTCGGCTTCGGCGGCCACAACGCCGTCCTCGTAGTGCGCAGCCTCAAGGAGGAAGAGAGTTATGCCGCGTAA	MRAHETRPLRRVVVTGTGVITPIGNTVESFWQSLIDGRSGISAIESWDASDLPVRIGAEVKDFDPAAYMPHKVSRRMDPSAQYGLAAAMEAVREAKLEMSDDLAARTGVYLGSSVGAAQMTYDTTVKLHERGARAVSPFFFATSGSESAAGEVAMWLGARGPSSSLSTACASGATCIGEAARLIQFGVTDVMIAGGAEAPVTRLNIAGAAACQALSRRNDDPSLACRPFDRERDGFVMGAGAGVVVLEEYEHALRRGAHILGELAGYGATTDAYHLTAPHPDALGTKTAMRIALESAGLQPQDVDYINAHGTSTQLNDSTEVSAIRGVFGEHATRIPVSSTKSMTGHLISATGAVELIAALLAVRRDVVPPTLNCNDPLDPDINFVPGVAQEWEVDVAMSNSFGFGGHNAVLVVRSLKEEESYAA	MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI	41.38	gnl|BL_ORD_ID|1179|hsp_num:0	1252		
BGC0001382.1|Svaricin_15 # 16043 # 16507 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.714	BGC0001382.1|Svaricin_15 	16043	16507	+	Loose	700	24.6386	ACT-4	26.76	3001829	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGCCGCGTAACGATCTGATGGACACCGCAACGCTTCCGTCCGGGGAGAAGGGCTACGTCGCCCGGCAGGACGTTCCCGCGGGCGCCGTCGTCGGCTCCTGGGAGGAGTCGGCGGTCGACTCCGAGCCCACGAAGTTCACCATCCAGGTCGGCCGCGACCGTCACGTCGACGCCGACGCGGTGCGCTACCTCAACCACTCCTGCGTGCCGAGCACGTTCGTCGACGCCTCGACCGGCAGCGTCGTGGCCCTCCGCCCGCTCGCCGCGGGTGACGCGCTGACGTTCTTCTACCCGTCCACGGAGTGGGAGATGACCACGCCGTTCGACTGCGCCTGCGGCCACGCCGGCTGCCTCGGCAAGATCACCGGCGCCGAGGCGCTCTCCGCTGACGTGCTGCGGCGCTACGCCGTGAACGACCACATCCGCGCCCTGGTCGCCGACCGGGACGCCGTCGCGCTGGGCTGA	MPRNDLMDTATLPSGEKGYVARQDVPAGAVVGSWEESAVDSEPTKFTIQVGRDRHVDADAVRYLNHSCVPSTFVDASTGSVVALRPLAAGDALTFFYPSTEWEMTTPFDCACGHAGCLGKITGAEALSADVLRRYAVNDHIRALVADRDAVALG	MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVADNASLLRFYQNWQPQWKPGTTRLYANTSIGLFGALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMVNMKPDSLQDNSLRQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVEAAYRILSAL	40.53	gnl|BL_ORD_ID|1407|hsp_num:0	1495		
BGC0001382.1|Svaricin_16 # 16611 # 18221 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.738	BGC0001382.1|Svaricin_16 	16611	18221	+	Loose	1200	26.5646	tet36	22.05	3000197	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGCCATCCGTCGGAGAACTACTGGTCTCCTCACTGCACGAGCACTCCGTCGACGTGGTGTTCGGCATTCCGGGAACGCACAACCTCGGGATCTACGCCCACCTCGAGCGGTACGGGCTGCGCCATGTCACGCCGCGGCACGAGCAGGGAGCGGGCTATGCCGCGGACGGCTACGCCCGGGTGTCCGGCCGCCCCGGTGTGGTGATCACGACGAGTGGTCCCGGCGTGCTCAACGCCGCCGCCGCCGCGGGCCAGGCGTACTCCGACTCCGTTCCCCTGCTGGTGATCTCGCCGGGCATGCCGTCGGAGCACCACAGGGGAGACGGGCTGCTGCACGAGACCAGGGACCAGTCCGCGGCACTCGCCGCGGTCTGTTCCGCCTCGTACCGCGTGACCCGTCCCGTGGACCTTCCCGTTCTCGTCGCCTCGCTGTTCGCGGGGTTCGCCTCGGGCAGGCCGCGCCCGGTGCACCTCGAGATCCCCTACGACCTGCTGGACGCCGACGTCGACCCCGTACCCCTGCCGCCGCCCCTGCCCGTCGCGCTCCCGGTCCCCGACGAGGAGGCCGTGGCCGCCGCGGCACGCACCCTGACGGCCGCCCGCCGCCCGGTGGTCGTCGCCGGGGGCGGGGCCCGGGCCGCCGCCGCCGAGCTGTGCCGGATCGCGGAAGCGCTCGACGCGCCCGTGGTGACCACCGCCAACGGCAAGGGCGTGCTCGCCGAGAGCCATCCGCTCTCCCTCGGCGCCGCCCTGCACGTCCCCCGGGTGCAGGAGCTCCTCGAGGCCGCCGACGTCGTCCTGGCCGTGGGCACCGAACTGTCCGAGACCGACACCTGGAACGGCCCCCTGCGCCTGTCCGGTCGCGTCGTCCGCGTCGACGTCGAGGCCGGCCAGATGCACCGGAACGCCGTCGCCGCCCATCCCCTGACCGGGGACGCGGCGCAGGTGCTGTCCGGGCTCATGAAGCATCTCCGCTCCGTCCCTTCCCTCCCCCGTGTCCCCGGGCGGAGCGGAGACACCCCCATCGCCCCCGCGGTCCGCTCCGCGGTGCGCGCCTACGTGCGGCGCTGGCGCGACGTCGTCGGCGCACTGCGGAATGCCCTGCCTGCCGATGCCGTCCTGGCCAACGACAGCGCGATGGCCTGCTATTTCGGAGCCATCGCGGGCTTTCCCGTGGAACGGCCGGGACGATTCCTGTACCCGACCGGCTTCGGCACCCTCGGCTACGCGCTCCCCGCCGCCATCGGCGCCGCGGTGGCACGGCCCGGCCGGCCGGTCGCCGCGCTGAGCGGGGACGGCGGGCTCCAGTTCACGGTGAACGAGCTCGCCACCGCCGTGGAGCTGGGCGCCCCCCTTCCGATCGTCGTCGTGTCCAACGGCGGTTACGGCATGATCCGCCAGGAGATGGCGGAACGGGGGCAGCCGGCCGTCGGAGTGGACCTCACCACCCCCGACTTCGCGGCCCTCTGCCGTGCCTACGGAGGGCACGGCAGCCATGTCACGTCACCCGACGAACTGCACGACGCCGTGGCGCGTGCGCTCACCGTTCCGGGCCCCACGGTCGTGGTCGTCCCGGAGCCACCCGCATTGTCCGAACCGCCATCCGCCTGA	MPSVGELLVSSLHEHSVDVVFGIPGTHNLGIYAHLERYGLRHVTPRHEQGAGYAADGYARVSGRPGVVITTSGPGVLNAAAAAGQAYSDSVPLLVISPGMPSEHHRGDGLLHETRDQSAALAAVCSASYRVTRPVDLPVLVASLFAGFASGRPRPVHLEIPYDLLDADVDPVPLPPPLPVALPVPDEEAVAAAARTLTAARRPVVVAGGGARAAAAELCRIAEALDAPVVTTANGKGVLAESHPLSLGAALHVPRVQELLEAADVVLAVGTELSETDTWNGPLRLSGRVVRVDVEAGQMHRNAVAAHPLTGDAAQVLSGLMKHLRSVPSLPRVPGRSGDTPIAPAVRSAVRAYVRRWRDVVGALRNALPADAVLANDSAMACYFGAIAGFPVERPGRFLYPTGFGTLGYALPAAIGAAVARPGRPVAALSGDGGLQFTVNELATAVELGAPLPIVVVSNGGYGMIRQEMAERGQPAVGVDLTTPDFAALCRAYGGHGSHVTSPDELHDAVARALTVPGPTVVVVPEPPALSEPPSA	MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRASTTSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLEIPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETILEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFIETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFYSGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRSKLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTIYKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFDGVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPILDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQGLGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK	83.75	gnl|BL_ORD_ID|1611|hsp_num:0	1708		
BGC0001382.1|Svaricin_17 # 18241 # 19428 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.713	BGC0001382.1|Svaricin_17 	18241	19428	+	Loose	1800	27.335	MexD	27.94	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGGACAGCAGCCCTACCTGCACGTGACCTGGACCGACGACACGACCGGCGCGACCGGCCACCTGGTGATCGACCGCCTGCTGCGCGGAGCGTCGAGCGGCGGGTTGCGCATGCGGTCCGGTTGCACCCTCGAAGAGGTCGCGGACCTCGCCAGGGCCATGACCCTGAAAGAGGCCCTGGTCTACCGGCCCGAGGACCACTACGCACCCTTCGGAGGTGCCAAGGGCGGTATCGACTTCGATCCGTCGCACCCGGACGCCCCCGCCGTGCTCGAACGGTTCCTGCGGGCCGTCCGGCCCCTCGCCGAGACCTACTGGTCGGTGGGCGAAGACCTCGGCACCCGGCAGGAGGACATCGACCGGGCCTTCGAGCGGATCGGCCTCCGTTCCTGTGTCCACGCCGCGCTGCCGTTCGTCGAGGACGGTGCCGACGCCGGACTGACCCGGATCTCCGACGCGTTCGCCGTGGAGGTGGACGGTCTCGGACTCGGAGACACCGTGGGCGGCTACGGAGTGGCCCAGTCGGTCCTGGCCGTGCTGTCGGAGCACCACGAACTGCCGGGCGAACAGACCGCGGTGGTCCAGGGCTTCGGCTCCATGGGGGGTGCCACCGCGCGCTATCTGGCCCGTGCGGGGATCCGGGTCGTCGCCGTCGTCGACCGGGACGGCGTCGTCCTCGACGAGCGGGGTGTCGACGTGGAGCGGCTGCTGGCCGACCGCAGCCCGGCCGGCCTGGTGAACCGGGAGACCCTGCCGCAGGGGGTCACCCTGCTCCCGGTCGAGGACTGGCTCACGGTCGAGACCGACATTCTCGTCACCGCCGCCGCCTCGTACGCCGTCGACGAAACCAACCACGCCGATGTGCGCTGCCGATATCTGGTCGAGGGGGCGAACGTCTCGGTACTGCCGGGCGCCGAGGCGGCACTCGCGGCGCGCGGCGTCGTCGTCGTGCCCGACTTCGCCGCGAACTTCGCCGCCAACAGCTGGTGGTGGTGGACCCTCTTCGGGGACATCGGCCCGGACGCCGACCAGGCCCTCACCAAGATCGAGAAGACGATGCGGGAGATCACGACCGCGATCTTCCAGCGGGTCAGGGAGACCGGGGCGACCCCGAGGCAGGCCGCGACGGCGATCTCCGAGGAGAATCTGCGTCAGGCCCGGGTCCGCTACGGCGACCTCCCGGCCTGA	MGQQPYLHVTWTDDTTGATGHLVIDRLLRGASSGGLRMRSGCTLEEVADLARAMTLKEALVYRPEDHYAPFGGAKGGIDFDPSHPDAPAVLERFLRAVRPLAETYWSVGEDLGTRQEDIDRAFERIGLRSCVHAALPFVEDGADAGLTRISDAFAVEVDGLGLGDTVGGYGVAQSVLAVLSEHHELPGEQTAVVQGFGSMGGATARYLARAGIRVVAVVDRDGVVLDERGVDVERLLADRSPAGLVNRETLPQGVTLLPVEDWLTVETDILVTAAASYAVDETNHADVRCRYLVEGANVSVLPGAEAALAARGVVVVPDFAANFAANSWWWWTLFGDIGPDADQALTKIEKTMREITTAIFQRVRETGATPRQAATAISEENLRQARVRYGDLPA	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	37.87	gnl|BL_ORD_ID|1525|hsp_num:0	1523		
BGC0001382.1|Svaricin_18 # 19688 # 20320 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.692	BGC0001382.1|Svaricin_18 	19688	20320	-	Loose	400	37.3502	MexL	24.61	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGACAGAAGCGCACCCTTGGTGTGGTGGTGGATTCCAGTGGAGCCCACCGAAGGGACCTGGACGCCCGTGACCGCGTCCTTGCCACCGCGATGAAGATGCTCGGCGAACACGGCTACTCGAAACTCACCATCGGTGGCGTGGCGGCCGAGGCGGGCGTCGGGAAGGCGACGCTGTACCGGTCGTGGCCCAACAAGGCGGCACTGGTGCTGGACGTGATCCGTGGCGAGCTCCGGGACGTGCCCACGGAGGACCTGGGCGACAGCCGTGCCGAGATGCTGGCGCTGGCGTCGCAGGCGCTCGGCCAGTTCTACGGCTCGGATCGGATCAGGACCGTGCTGCCGGCCCTCGTCGGTGACCTGTCGGAGGATTCCGCGCTGCGCCAGCGGCTGTGGGAGGAGATCGTCGACGCCCGCAAGAAGCAGTCGATGACCGTCATGGAGCGGGCGTTGGGCCGGGGCGACCTGCCTGCCGACACCGACGTCTCGCTCGTTCTCGACATGTGGGCGGGCACGATGCTGTTCCGCGCGCTCTTCTCGGCGGACGCCATGGACGACGAGACCATCGAGCGGTTCGTCGACGCCACCATCGCGTCCCCGCCCCGCACGGGCGGTTCGCAGCCCGTCCGCTGA	MGQKRTLGVVVDSSGAHRRDLDARDRVLATAMKMLGEHGYSKLTIGGVAAEAGVGKATLYRSWPNKAALVLDVIRGELRDVPTEDLGDSRAEMLALASQALGQFYGSDRIRTVLPALVGDLSEDSALRQRLWEEIVDARKKQSMTVMERALGRGDLPADTDVSLVLDMWAGTMLFRALFSADAMDDETIERFVDATIASPPRTGGSQPVR	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	99.06	gnl|BL_ORD_ID|2067|hsp_num:0	2219		
BGC0001382.1|Svaricin_19 # 20482 # 22113 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0001382.1|Svaricin_19 	20482	22113	-	Loose	910	327.791	lfrA	42.49	3003967	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGGAAACACGCGCTGCTGAGCGAACGCCGGAAGTGGGCCACGCTGGCGACCGCCTGCCTCACGATGCTGCTGCTCTCGGTGGACCTGACCGTCCTGCACCTGGCCGTTCCCCGGCTGACCGCGGAGCTGCGGCCGACGTCCACCCAACTGCTGTGGATCGCCGACGTGTACGGCTTCGCGCTCGGCGGGCTGCTCATCACGATGGGCAACGTGGGCGACCGGGTCGGCCGCCGACGACTGCTCCTGGTGGGCACGTTCGGGTTCGGTGCGGCATCCGGGCTGACGGCGTACGCGTGGAACGCGGAACTGCTCATCGTGGCGCGCGCCCTGCTGGGGGTCGCCGGCTCGACGCTCATGCCGTCGACGCTCTCGATCATCCGGAACACGTTCACTGATCCGGTCGAGCGGACCCGGGCGATCGGGATCTGGTCGAGTGTCAGCTCCGCGGGTTTCGCCGTGGGGCCGCTGATCGGCGGTCTGCTGCTCGACCACTTCTGGTGGGGGTCGGTCTTCCTGATCAACATCCCGGTGATGCTGCTCATCTTCGTCGTCGGCTTCTTCGTGCTGCCCGAGTCGAAGAACCCGCGGCCCGGGCGGCTGGACGCCCTCAGTGTGCTGCTCTCGGTGGCCGGCATCGCCGCCGTCATCTACACGATCAAGGACGCCGCGCACGACGGGTTCGCCCAGACGGACGTGGCGGTGGCCTGTGTCGTCGGCGTCGGGGCCCTGGCGCTCTTCGCCTGGCGGCAAGGACGCCTGGAGACTCCCCTGATCGACGTCGCACTGTTCCGGAACCGGGGCTTCAGTGCCTCGGTGGGCGCCACGGTGATGGCCATGTTCGCCCTGGCCGGAGTGGGGTTCGTAGGATCGCAGTACTTCCAGGTGGTGCTGGGCTGGTCACCGCTCCGTTCGGCGGTCGCCCAACTGCCGGGCGTGGCCGGGGCCGTGGCCGGGGCCGTTCTGGCGCCGAAGCTGGCGGCCGCCGCGGGCCGGGCCCGCACGGTCGCGCTGGGACTGACGCTGGTGTCCGTCGGACTGCTGCAGTACCTGTGGCTGTCCACGGAGGTCTCCTACCCTGCGGTCCTCGCGGCGCTGATCGTGACCAGCTCCGGGGTCGCGATGACGTTCACCGTGACCGCCGACAGCGTGTTGGAGTCCGTCCCCAGGGAACGCGCCGGAGCCGCCTCGGCGATCTCCGAGACGGCGTACGAGATGGGTGGCGCCCTGGGCATCGCGGTGCTGGGCAGTGTGCTGAGCCGTGTCTACCGCGACGGCCTGGACATGCCGCCGGGGATCCCCGGGGAACACGGGGCCGTCGTCAGGGAGTCGCTCGCCGGCGCCATGGACGTCGCGGGCCGGCTGACCGCCGATCTCGGCGCGGCGCTGGCGACGACGGCACGTGAGGCGTTCATAGGCGGATTCCACGCGACGGTGGCGGCCTGCTCGGGACTGGCCGCGATCGTGATGGTGACCACATGGATCGCCCTGCGCGGAGCCCCCGCGCAGGGCCCCTCGGAGACCGCCGGCGAGGAGGCCGCTCCCGCGACCCCTCCCGCCCGGTCGTCCGGTGACCCGGACACGCTGGTGCTGGTGGCGGACTCCGCGCAGCGGGCGACCACCGGTCCGTGA	MGKHALLSERRKWATLATACLTMLLLSVDLTVLHLAVPRLTAELRPTSTQLLWIADVYGFALGGLLITMGNVGDRVGRRRLLLVGTFGFGAASGLTAYAWNAELLIVARALLGVAGSTLMPSTLSIIRNTFTDPVERTRAIGIWSSVSSAGFAVGPLIGGLLLDHFWWGSVFLINIPVMLLIFVVGFFVLPESKNPRPGRLDALSVLLSVAGIAAVIYTIKDAAHDGFAQTDVAVACVVGVGALALFAWRQGRLETPLIDVALFRNRGFSASVGATVMAMFALAGVGFVGSQYFQVVLGWSPLRSAVAQLPGVAGAVAGAVLAPKLAAAAGRARTVALGLTLVSVGLLQYLWLSTEVSYPAVLAALIVTSSGVAMTFTVTADSVLESVPRERAGAASAISETAYEMGGALGIAVLGSVLSRVYRDGLDMPPGIPGEHGAVVRESLAGAMDVAGRLTADLGAALATTAREAFIGGFHATVAACSGLAAIVMVTTWIALRGAPAQGPSETAGEEAAPATPPARSSGDPDTLVLVADSAQRATTGP	MSTCIEGTPSTTRTPTRAWVALAVLALPVLLIAIDNTVLAFALPLIAEDFRPSATTQLWIVDVYSLVLAALLVAMGSLGDRLGRRRVLLIGGAGFAVVSALAAFAPSTELLVGARALLGVFGAMLMPSTLSLIRNIFTDASARRLAIAIWASCFTAGSALGPIVGGALLEHFHWGAVFLVAVPILLPLLVLGPRLVPESRDPNPGPFDPVSIVLSFTTMLPIVWAVKTAAHDGLSAAAAAAFAVGIVSGALFVRRQNRSATPMLDIGLFKVMPFTSSILANFLSIIGLIGFIFFISQHLQLVLGLSPLTAGLVTLPGAVVSMIAGLAVVKAAKRFAPDTLMVTGLVFVAVGFLMILLFRHNLTVAAIIASFVVLELGVGVSQTVSNDTIVASVPAAKSGAASAVSETAYELGAVVGTATLGTIFTAFYRSNVDVPAGLTPEQTGAAAESIGGAAAVAADLPAATATQLLDSARAAFDSGIAPTAVIAAMLVLAAAAVVGVAFRR	107.74	gnl|BL_ORD_ID|2249|hsp_num:0	2433		
BGC0001382.1|Svaricin_20 # 22144 # 25488 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.762	BGC0001382.1|Svaricin_20 	22144	25488	-	Loose	1500	26.9498	Escherichia coli gyrA with mutation conferring resistance to triclosan	32.05	3004335	protein variant model	D87G	D87G:1545, D87G:2850	triclosan	antibiotic target alteration	triclosan resistant gyrA	ATGCGTTTCGACGTACTGGGCCCCGTGGAGATGAGGAGGGCCGACGGAGCGGCGGTGCCGGTGGGCGGCCCCAGAGTGCGCGGCCTGCTGGCGCTGCTCCTCCTCGGCGCCGGCCAGGTCGTCCGCACGGAGCGCCTGATCGACGGCCTGTACGGCGACCGCCCACCGCGCCACGCGACCCGGGCCCTCCAGTCGCAGGTGTGGCGGCTCCGCCACGCGCTGGACGGCGAAGCGGAGGTGGAGTTCCACCAGTCCGGATACCGGCTCGCCGTGCAACCCGAGTCCGTCGACGCCCATCGTTTCGAACAGCTGGCCGCCGCCGGACGACGGGCGCTGGACTCGGGAGAGTCCGCCCGTGCCACCGAGGCGCTCGACGAAGCGCTCTCGCTCTGGCACGGGGCGGCGCTCTCCGGGGTCGCCGAGACGCCGTTCCTCGCCGCCCAGGCCGCACGCCTGGAGGAACTGCGCTTCACCGCGCTCGAGGACAGGGCGGACGCCGAACTCCTGGCGGGGCGCTGCCGCGGCCTGGTCGCGGAACTGCGCGAGCGCATCTGCGCGGGCCCGCTGCGGGAACGTCCGCGTGGCCAGCTCATGCGCGCGCTCCACGCCTCCGGGCGGACCGCCGAGGCCCTCGCCCTCTACGAGGAGACCCGCCGGGTCCTGGCGGCCGAACTCGGCACGGAACCGGGGGCCGAACTGCGGGCCGTGCACCTCTCGGTCCTGCGCGACGAGCCGGCGGACACACCGCCCCCGGTGGCACTCCGCGCCCGCGGAACCCTGCCACCGCGGAGCGGGCCGGGCCCGGTACCGGCCGCGGCCGGCGCACCGCCGGCCGGGGCCCGGCGGCCCACAGCACCCACCGCACCCACCGCACCCACCGCACCCACCGCGCCGGGTCCTGCCCGGCGGCACCGGCTGCCCGCGCCGCTCACGAGCTTCGTCGGCCGCGACGAGCCGGTCCGGCGCCTCGGCGATCTCCTCGACGAGGTCCGCCTGGTCACGCTCACCGGCCCGGGCGGCTCCGGGAAGACCCGTCTCGCGATCGAGACGGCCACCCGCCGCGAAGGGGACGTGTACCTCGTCGAACTGGCCGGCCAGGCCCCTGCGACCGACGTCCCGCGGGCGGTCCTCGACGCCCTCGGCATCCACGACGCGCCCGTGCTGCCGGTGGCGCCTGCCGGCCGCAGGCGCGGCGGGTCGCCCGTGACCGATCGGCTGGTCTCGGCCCTCGCCGACCGCCGCTCCCTCCTCGTGCTCGACAACTGCGAACACGTCGTCGAGGACGTCAGCCGCCTCGCCCAGGAACTGCTCGACGGCTGTCCCGGCCTCACCGTGCTGGTCACCAGTCGCGAGGCCCTCGGCATCACCGGTGAGACGCTTCTCGCCGTGACGCCCCTGGAGGTGCCGCCGGCCGACGGCGGCACCGACCCGGAGCACGCGCTGCGCTATGCGGCGGTGCGGCTGTTCACCGATCGCGCCCGGGCCGTGCGCTCCGGCTTCGTCCTCGACGCGGAGACCGTCCGGCCGGTGCTGAAGATCTGCCGCGCACTCGACGGTCTTCCGCTCGCCATCGAACTCGCGGCGGCGCGACTGCGCTCACTTCCCCTGGGCGAACTCGCCGCACGGCTCGACGACCGCTTCGCGCTGCTGTCCCGGGGCAGCCGCACGGCGCCGCCGCGGCACCGCACCCTCAGCGCGGTCGTCGACTGGAGCTGGGACCTTCTCGACGAGGAGGAACGCACCCTGGCCCGCCGCCTCTCGGTGTTTCCCGCCGGCGCGACGCAGGCCGCGGCCGAGCGCGTCTGCGGACCGTTCTCCGGCAGCACCCTCGACCTGCTCAGCTCCCTGAGCGACAAGTCGTTCGTCACCGCGACGGGCGAGGCCGAGCCGCGCTTCAGAATGCTGGAGACGGTACGGGCCTACTGCGCGCGGCGGCTGGCCGAGGCCGGGGAGACGGAGTGGATCCGCCGCGCGCACGCCGCGCACGTGACCGAGCTCGCCGAGGCAGCCGCACCCCATCTGCGCGACGCGGCCCAGCTCGACTGGCTCTCCCGGCTGACCGCGGTCCACGACGACATCGTCGCCGCCCTGCACTGGTCCACTCGCGCGGACCCCGCCCGGGCCCTGCGGCTCGCCGCGGCGCTGTGGTCCTACTGGTGGCTGCGCGGCCCGGCCGGTGAGGGCGCCGAGCGGATGCGGGACGTCCTGGTGTCCGCCGGTACCACTCCCCCGCCCGATCTCGCGGCGCAGTACGTCATCTGCGTGGCCGGCACCGTGCTCTCCATGCGACCGACGCCGGATCTGCACTCGCACCTGCGGGCCGCCGTCGCCCTGGGAGACGGCCTGGACACGGCCGGCGCCCATCCGCTGGTCGCCCTGATCCGGCCGGTCGTCGCGCTCGCCACCGGCGACCACGACGCCGAGCTGCCCCCGTTCCCGGACGCGGGACGGGCCGAGCCGAACGCCCCGGACGGGGACCCGGCACTGCGGGCCGCCATGCACCAGCTGCTGGGCATGCTCCACCAGGGACGCGGCCGGCCCGACCGCGCGGAGCGCTGGTTCACCGTGGCGCTCGACGGCTTCCGCGCGTCGGGCGACCGTCTCGGCGCCATCCAGGTCCTGCCCGAACTGGCCCGGATCGCCGGGTGGAACGGTCACCACGAGCGTGCCGTGGCGTTCGTCGACGAGGCTCTCGCCCTGGCGGTCCAGCTCGGTTCCACCACCAACGAGGCCTACCTCCTCGGCCGTCGGGCCGCCGAGCGCCGCAGCGTCGGCGACCTCGCCGGCGCCGAGACCGACAGCGCGGCAGCCGGACGGCTGGCACGCGCCGCGGACGCGCCGGAACTGGTGGCGGCGGCGCAGCATCACGCCGGTGAGACGGCCCGGTTGCGCGGGGACCACGCGAGCGCGCGACGGTTCCTGGAGTCGGCGCTCCGCGGCTGCGGGGGGACCTGGCTGGGCGAGGAGATCCGGGTCAGGACGCTCACCGCCCTCGGCCGGGTCAGCCAGGCAGAGGGAGACCCGGGCGGGGCGCGCGAGCGGCACGGGCGTGCGCTGGACATCGTTCTCGTCGGCTGGGACCTGGCGACCATCGCCGACACGGCCGACGGCCTGGCCGGCGTTCTCGTGGCCGACAGCCCGGTCACGGCGGCCACCGTCCTCGGCGCGAGCACCGCGCTCCGCGGGGTGCGGGCCACGGACCGGGACACGGTGCTCGCCGTCCGGGACGCCCGCCGGCACCTCGGAGCGCGGGCGTTCCGCCAGGCATACGGGGCGGGGTCCGCGCTGACCCGGCAGGAGGGTCTCGCACTGCTCGCGAGGGCGCTGTCAGAGATCCGTGAGTGA	MRFDVLGPVEMRRADGAAVPVGGPRVRGLLALLLLGAGQVVRTERLIDGLYGDRPPRHATRALQSQVWRLRHALDGEAEVEFHQSGYRLAVQPESVDAHRFEQLAAAGRRALDSGESARATEALDEALSLWHGAALSGVAETPFLAAQAARLEELRFTALEDRADAELLAGRCRGLVAELRERICAGPLRERPRGQLMRALHASGRTAEALALYEETRRVLAAELGTEPGAELRAVHLSVLRDEPADTPPPVALRARGTLPPRSGPGPVPAAAGAPPAGARRPTAPTAPTAPTAPTAPGPARRHRLPAPLTSFVGRDEPVRRLGDLLDEVRLVTLTGPGGSGKTRLAIETATRREGDVYLVELAGQAPATDVPRAVLDALGIHDAPVLPVAPAGRRRGGSPVTDRLVSALADRRSLLVLDNCEHVVEDVSRLAQELLDGCPGLTVLVTSREALGITGETLLAVTPLEVPPADGGTDPEHALRYAAVRLFTDRARAVRSGFVLDAETVRPVLKICRALDGLPLAIELAAARLRSLPLGELAARLDDRFALLSRGSRTAPPRHRTLSAVVDWSWDLLDEEERTLARRLSVFPAGATQAAAERVCGPFSGSTLDLLSSLSDKSFVTATGEAEPRFRMLETVRAYCARRLAEAGETEWIRRAHAAHVTELAEAAAPHLRDAAQLDWLSRLTAVHDDIVAALHWSTRADPARALRLAAALWSYWWLRGPAGEGAERMRDVLVSAGTTPPPDLAAQYVICVAGTVLSMRPTPDLHSHLRAAVALGDGLDTAGAHPLVALIRPVVALATGDHDAELPPFPDAGRAEPNAPDGDPALRAAMHQLLGMLHQGRGRPDRAERWFTVALDGFRASGDRLGAIQVLPELARIAGWNGHHERAVAFVDEALALAVQLGSTTNEAYLLGRRAAERRSVGDLAGAETDSAAAGRLARAADAPELVAAAQHHAGETARLRGDHASARRFLESALRGCGGTWLGEEIRVRTLTALGRVSQAEGDPGGARERHGRALDIVLVGWDLATIADTADGLAGVLVADSPVTAATVLGASTALRGVRATDRDTVLAVRDARRHLGARAFRQAYGAGSALTRQEGLALLARALSEIRE	MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMATNIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNVAAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVVVTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVYSMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVLTEFNRLRTAGKVAIKLVDGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTGVRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERNGLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVAEPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE	127.31	gnl|BL_ORD_ID|2524|hsp_num:0	2851		
BGC0001382.1|Svaricin_21 # 25509 # 25706 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.591	BGC0001382.1|Svaricin_21 	25509	25706	-	Loose	500	26.5646	mphL	32.69	3003072	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAAACGGGGGAACGCTGCTTTGACGCGAGCTGAAGAGGGCCGTGACGATACCGTCCGGCCCGCCATCGACATGCCCGAGGAGACCTTTCTCCTCGAAATTCCCACCCTTCCCGAGATTCTCGGGACCATCTTCTCCGGAGGACCTCTTGAAGCCATTCGCAATGGTTCGGGAAAACAGACGCCAGCAGTCGGCTGA	MKRGNAALTRAEEGRDDTVRPAIDMPEETFLLEIPTLPEILGTIFSGGPLEAIRNGSGKQTPAVG	MEEIKMNTLKIKQLATKEGLNILEDSIKINESGVDFQVAHAKEQNGDKWILRIPRRPESMRHVLQEKKALEIIKNHAGFQVPDWSIFTEDLIAYKQLSGVPAATIDIEQQGYIWSFNEKNAPSEYHISLGKVLANLHSLPQQEFNNIGIEILTANELRASMEQRMNRVKEQYYVNQKLWDRWQAWLTEDSFWPSHVGVTHGDIHPGHILIDKKNNVTGLIDWTEVGIADVSIDFTSHYLLFGKDGLTKLISSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKEMHEAAVHMLATES	21.45	gnl|BL_ORD_ID|2399|hsp_num:0	1240		
BGC0001382.1|Svaricin_22 # 25996 # 26472 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.719	BGC0001382.1|Svaricin_22 	25996	26472	+	Loose	1450	23.8682	BahA	50.0	3003984	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	Bah amidohydrolase	ATGCAGCGGCTGTGGGAAGTGGAAGAAAGCATTCACGTCAAGGCCGCGGCGGACACGCTCTACGACTCCGTTGCGGACGTCAGGGCGATGGGCAGGTGGAGCCCGGAGTGCCGGAGGGTCTGGCTGCCCCGGCCGCCCGTCCGCCGGGGCAGCGGCTTCGTCGGCTTCAACCGCAAGGGGCCGTGGGTGTGGTTCACCTGGTGCCGCGTCGTGCGTGCCGAGCGGCCCCACGCCTTCACCTTCCGGGTCAGCACCTTCGGCCTGCCGGTCGCCGAGTGGGGCTACCGCTTCACGCCCACCGACGACGGCACCCGGGTCACCGAGCACTGGACCGACCTGCGCACCGGACGCGGGGCCCGGCTCACCGAACTGCTCGGACTGGTGTTCACGGGCACCCGTCCGCGCCTGCGCGCCGCACGCAACCGGGCCGGCATGCGCACCACACTCCACCGACTGAAGCAGGCCGCCGAAGGCTGA	MQRLWEVEESIHVKAAADTLYDSVADVRAMGRWSPECRRVWLPRPPVRRGSGFVGFNRKGPWVWFTWCRVVRAERPHAFTFRVSTFGLPVAEWGYRFTPTDDGTRVTEHWTDLRTGRGARLTELLGLVFTGTRPRLRAARNRAGMRTTLHRLKQAAEG	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	21.01	gnl|BL_ORD_ID|2291|hsp_num:0	2521		
BGC0001382.1|Svaricin_23 # 26513 # 27565 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=15bp;gc_cont=0.705	BGC0001382.1|Svaricin_23 	26513	27565	+	Loose	450	25.0238	vanSD	28.12	3002934	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGGAACCGACCACCACCACACCGGCGTCCGGTGTCACCGCGTCCTTCGAGCCGCTCCGGCGCGCGGTGCGCGAAGCCGGCCTGCTGGCACCACGACCCGCCTACTACGTACTGAAGTTCGCCACGAACACCGCACTGCTCGCCGGCGCCTGGACCGTGTTCTTCCTGCTCGGCGACTCGTGGTTCCAGCTGCTCACCGCCGTGCTGCTGGCCTTCGCCTACGGGCAGACCGGACTGCTCGGCCATGACCTGGGTCATTCCCAGGTGGTGCCCGGCCGCCGGGCGACGGAAGTGCTCGGACTCGTCCACGGCAACCTGCTCCTCGGCTTCAGCTACGGCTGGTGGATGAACCACCACGGGCGTCACCACAGCCATCCCAACCACCTCGAGCTCGATCCGGACATCCTGCGCCGGGTGGTCGCCTTCTCCCCGGAGCAGGCGCGGAGGAGCCGCGGCGTACGGGCGTTCGTGATCCGCCACCAGGCGGGGCTGTTCTTCCCGCTGCTCACCCTGGAGGCGTTCGGCCTCCGCATCGCCAGCGCCGTCGCCATACGCCGCGGGGCCGTCCGCAGGCCCGGGACGGAAGCCCTGCTGATGGCCGTCCATCTCGCCGCGTACAACGCCGCCCTGTTCCTCACCCTCCCCTTCGGCCTGGCGCTGGCCTTCTTCGCCGTTCACCAGGGGCTGTTCGGCGTCTACCTGGGCTGCGTCTTCGCCCCCAACCACAAGGGCATGCCGGTGCGGGACAGCGGCGAGGAGCCCGGCTGGCTCGCCCGCCAGGTGCTCACCTCGCGCAACATCCGCAGCTCCCGGCCGCACGACTTCTTCTACGGCGGCCTCAACTACCAGATCGAGCACCACCTGTTCCCGACCATGCCGCGCCCGAACCTGAGGCGCTGCCGGCCGCTCACCATGGCCTACTGCGCCGAAGTGGGCCTGCCGTACCACGAGGTCTCCGCGACCCGTTCCTACGCAGAGGTCCTGCGCCACCTCCGGCTCATCGGCGGCAGCGCCGTACCGGACCTCGGCCGTCCGTCCCCCGCAGCACCGTGA	MEPTTTTPASGVTASFEPLRRAVREAGLLAPRPAYYVLKFATNTALLAGAWTVFFLLGDSWFQLLTAVLLAFAYGQTGLLGHDLGHSQVVPGRRATEVLGLVHGNLLLGFSYGWWMNHHGRHHSHPNHLELDPDILRRVVAFSPEQARRSRGVRAFVIRHQAGLFFPLLTLEAFGLRIASAVAIRRGAVRRPGTEALLMAVHLAAYNAALFLTLPFGLALAFFAVHQGLFGVYLGCVFAPNHKGMPVRDSGEEPGWLARQVLTSRNIRSSRPHDFFYGGLNYQIEHHLFPTMPRPNLRRCRPLTMAYCAEVGLPYHEVSATRSYAEVLRHLRLIGGSAVPDLGRPSPAAP	MKNRNKTSHEDDYLLFKNRLSVKILLMMACSILIIAGVYLFILKDNFANVVVAILDSFIYHDRDEAVVVYLRTFKAYEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVNEDANDITLPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLNLLRDENQISEELREKYLSISLDKAERLEELINEFFEITRLIFQISRLCTAKSI	150.21	gnl|BL_ORD_ID|2081|hsp_num:0	2139		
BGC0001382.1|Svaricin_24 # 27637 # 28875 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.711	BGC0001382.1|Svaricin_24 	27637	28875	+	Loose	2000	29.6462	adeJ	30.61	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCCGCCGTCTGTTCACGTCCGAGTCCGTCACCGAGGGACACCCCGACAAGATCGCCGACCAGATCAGCGACACGATCCTCGACGCCCTGCTGCGCGGGGACCCCACGTCCCGCGTCGCCGTCGAGACCCTGATCACCACCGGTCTCGTCCACGTGGCCGGGGAGGTCACCACCACCGCGTACGCGCCGATCGCCCAGCTGGTCCGCGACAAGGTCCTGGAGATCGGCTACGACTCGTCCGCCAAGGGTTTCGACGGAGCCTCGTGCGGTATCGAGGTGTCCATCGGAGCGCAGTCGCCCGACATCGCCCAGGGCGTCGACAGTGCCTACGAACAACGGGTCGAGGGGGCCCCGGGCGGGGCCGCCGACGAGCTCGACCGGCAGGGCGCCGGCGACCAGGGGCTGATGTTCGGCTACGCCTGCGACGAGACGCCCACGCTGATGCCGCTGCCCCTGGAGCTCGCCCACCGGCTCGCGCGCCGGCTCACCGAGGTCCGCAAGGACGGCACGATCCCCTATCTGCGTCCGGACGGGAAGACCCAGGTCACCATCGAGTACCTGGGAAGCCGCCCGCAGCGGCTGGACACCCTGGTCGTCTCCACGCAGCACGCCGCGGACATCGACCTCGACACCCTGCTGACCCCGGACGTCCGGGAGTTCGTCGTGGAGCCGGTCCTCGCCGCCCTCCACGAGGACGGCATCAAGCTGGACACCGAGGGCTACCGGCTGCTGGTCAACCCGACCGGGCGTTTCGAGATCGGCGGCCCGATGGGCGACGCCGGCCTCACCGGCCGCAAGATCATCATCGACACCTACGGGGGCATGGCCCGCCACGGTGGCGGCGCGTTCTCCGGCAAGGACCCGTCCAAGGTGGACCGCTCGGCCGCCTACGCGATGCGCTGGGTCGCCAAGAACGTCGTCGCGGCGGGTCTCGCCTCCCGCTGCGAGGTGCAGGTCGCGTACGCGATCGGCAAGGCCGAGCCCGTCGGGCTGTTCGTCGAGACCTTCGGCACCGCCCGCCATCCGCAGACGGCCATCGAGCGGGCCATCTCCGAGGTCTTCGACCTGCGCCCGGCCGCGATCATCCGCGACCTCGACCTGCTCCGCCCGATCTACGCCCAGACCGCGGCCTACGGTCACTTCGGCCGCGAACTGCCCGACTTCACCTGGGAGCGCACCGACCGCGTCGAGGCCCTGAAGGCGGCCGTCGCATCGAAGGGCGGCGACGCGCGGTGA	MSRRLFTSESVTEGHPDKIADQISDTILDALLRGDPTSRVAVETLITTGLVHVAGEVTTTAYAPIAQLVRDKVLEIGYDSSAKGFDGASCGIEVSIGAQSPDIAQGVDSAYEQRVEGAPGGAADELDRQGAGDQGLMFGYACDETPTLMPLPLELAHRLARRLTEVRKDGTIPYLRPDGKTQVTIEYLGSRPQRLDTLVVSTQHAADIDLDTLLTPDVREFVVEPVLAALHEDGIKLDTEGYRLLVNPTGRFEIGGPMGDAGLTGRKIIIDTYGGMARHGGGAFSGKDPSKVDRSAAYAMRWVAKNVVAAGLASRCEVQVAYAIGKAEPVGLFVETFGTARHPQTAIERAISEVFDLRPAAIIRDLDLLRPIYAQTAAYGHFGRELPDFTWERTDRVEALKAAVASKGGDAR	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	38.94	gnl|BL_ORD_ID|589|hsp_num:0	630		
BGC0001382.1|Svaricin_26 # 29752 # 30822 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.724	BGC0001382.1|Svaricin_26 	29752	30822	+	Loose	650	26.5646	vanG	25.0	3002909	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGTCCTCTCAGGACACCGCTGACACCGTTCTTCCCGAGGACGGGCCGGACGGGGGCGCCGGCGCCGACCTGCGCATCGCCGTCACCGGCTCCATCGCCACGGACCATCTCACCACCTTTCCCGGCCTGTTCGCGGACCAGCTGATCGCCGATCGACTGGACAAGGTGTCGCTCTCGTTCCTCGTGGACGACTTGGAGGTCCGCCGCGGAGGGGTGGCGGCGAACATCGCCTTCGGCATGGGCTGCCTCGGCCTCCGCCCGATCCTCGTCGGGGCGGTCGGAGCCGACTTCGCCGAGTACCGCGTGTGGCTGAAGGAGCACGGGGTCGACACCGAGTCCGTCCACGTCTCCGCCGAGCGCCAGACGGCTCGCTTCATGTGCATGACGGACCAGGCGCAGAACCAGATCGCCTCCTTCTACACGGGTGCCATGGAAGAGGCGGCCGGCATCGACCTGCACCCCGTCGCCGAGCGGTCGGGCGGGATCGATCTCGTGCTGGTCTCGCCGAACGATCCCCGGGCCATGCTCCGGCACACCGCCCAGTGCCGCGAGCTGGGCCTCCCGTTCGCCGCCGACCCCTCGCAGCAGCTGCCGCGACTGCGCCGCGACGACGTGCGCGACCTGGTCGACGGCGCCCGCTGGCTGTTCACCAACGAGTACGAGGCGTCTCTCCTGCTGGAACTCACGGGATGGCGGCACCGGGACGTCCTCGCCCGCGTGGGCCTCTGGGTCGTCACCCGTGCGGAGGCGGGCGTCACGCTCCACCGTGACGGCGACGCCCCCGTCACCGTCCCTGCCGTACAGGCCGGGCCGATCGCGGATCCGACCGGCGTGGGCGACGCCTTCCGGGCGGGTTTCCTCGCCGCCGCCGGCCGCGGTCTTGAGCCGGACGAGGCCGCCCGGTTCGGGTGCGCGATGGCCGTGCTCGCCCTGGAGAGCGTCGGTCCGCAGGAGTACACCGTCGCGCGAAGCGCACTCCTGCCCCGGATCGAGGCCGCGTACGGGCCGGTCACCGCGCAGGCGGTGGATGCGAGCGGGCTGCTCGGCCCCGGGAAGCGTCGACCGGGCTGA	MSSQDTADTVLPEDGPDGGAGADLRIAVTGSIATDHLTTFPGLFADQLIADRLDKVSLSFLVDDLEVRRGGVAANIAFGMGCLGLRPILVGAVGADFAEYRVWLKEHGVDTESVHVSAERQTARFMCMTDQAQNQIASFYTGAMEEAAGIDLHPVAERSGGIDLVLVSPNDPRAMLRHTAQCRELGLPFAADPSQQLPRLRRDDVRDLVDGARWLFTNEYEASLLLELTGWRHRDVLARVGLWVVTRAEAGVTLHRDGDAPVTVPAVQAGPIADPTGVGDAFRAGFLAAAGRGLEPDEAARFGCAMAVLALESVGPQEYTVARSALLPRIEAAYGPVTAQAVDASGLLGPGKRRPG	MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE	102.01	gnl|BL_ORD_ID|1093|hsp_num:0	1157		
BGC0001382.1|Svaricin_27 # 30926 # 31237 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.718	BGC0001382.1|Svaricin_27 	30926	31237	+	Loose	2200	24.2534	Bifidobacterium bifidum ileS conferring resistance to mupirocin	36.11	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGCGGCAGTTGATCAGTTCAATAATCGGCGGCGCAGTGTTCATGGCGGTCTCCGCGGCCGGAGCAGGGCACGCGGCGGCGACCGAAGGAGGCGAGCCCGCGCCCGAGTGCGTCCGGTACGCGGCGAGCTGGCGCTACACCCACGTCACCAACGACTGCGGCACCGCGCACCGGGTGACGGTGGAGTACACCGACGGTGCGGAAGTGCCCTGCCGCGAGACGCAGCCGGGGGCGACGGTCACCTTCCCCGGGTACGGCACCGGCGGCAACGGCGTTCTGCGCGTGCTGCTCTGCCCGCCGCAGCCCGTCTGA	MRQLISSIIGGAVFMAVSAAGAGHAAATEGGEPAPECVRYAASWRYTHVTNDCGTAHRVTVEYTDGAEVPCRETQPGATVTFPGYGTGGNGVLRVLLCPPQPV	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	9.30	gnl|BL_ORD_ID|2107|hsp_num:0	2278		
BGC0001382.1|Svaricin_28 # 31326 # 31934 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.739	BGC0001382.1|Svaricin_28 	31326	31934	+	Loose	1800	26.1794	mexY	31.88	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACACACGATTCCGCGAGGGCGAGGTCATCGTCCGCCGGGAGATGCTGGACGGCCGCGAATGGCTGGTCTACCCCGTGCGGGTGGCCGGTGACGACGAGCACGCGCTCGCCGTGTACCTGGCCCAGGGCACGCCGCTCACCTTCGGCCGCGGCGACTTCCGCTGGGGCCCGCACGCCTGGCTCGAGTTCGCGCACGTGTGGCAGTCGAGCGGGGTGCTCCAGCTCCAGCGCCCCGGCGAGGGCTACGCGGTGTGGGGCCGCCGGGAGAGCGGCGAACTGCGCGAGTGGTACGTCAACTTCCAGGCCCCGTACGCCCGTACGGAGCGCGGGTTCGACACCCTCGACCACGAACTGGACCTCGTCATCCCCGGCGACGGCTCCCCGTACCGGTGGAAGGACGTCGAGCACTTCGAGGAACGGGTGCGCACGGGCGGCTTCACGAGCCGGGAGGCTGCCGCCGTGCGGGCGGCCGCTGCCCGGGTCGCCGATCTCGTCGAACGCGGCGAGTGCTGGTGGGAGCGGTGGCGGGAGTGGACCCCGCCCGCCGGGTGGGACGTTCCCGGCGCCGTCGCCCTGACGGACGGCGGCGCTCCGGCCGCTCGCTGA	MDTRFREGEVIVRREMLDGREWLVYPVRVAGDDEHALAVYLAQGTPLTFGRGDFRWGPHAWLEFAHVWQSSGVLQLQRPGEGYAVWGRRESGELREWYVNFQAPYARTERGFDTLDHELDLVIPGDGSPYRWKDVEHFEERVRTGGFTSREAAAVRAAAARVADLVERGECWWERWREWTPPAGWDVPGAVALTDGGAPAAR	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	19.31	gnl|BL_ORD_ID|1687|hsp_num:0	1786		
BGC0001382.1|Svaricin_29 # 31941 # 33452 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.763	BGC0001382.1|Svaricin_29 	31941	33452	-	Loose	400	26.5646	ErmN	27.93	3000592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCTGCCGCCCCGGGATGCCGGGCGCAACGCGAGGCCGGAACGCCCCCGGTTCCGGGCCTCCGGTCGCGTACCGATACACATGGGGTCGACCAATCGAGCCGATCCGGGCCGTACGACCGAACCGTGGCCGTACAACCGGTTCGGCGGCACGACCGGGGACGCGGGGGCGGATCAGGTGGTACGTACAGCCGGTGCAGCGGGGCCCACGGGCCGGGAGCGGGGCGAACGGAAGCGGCACGAGACCCCGGGGGCACGGGGCGGGCCCGGGGAACGGGCGGGCCGGGGAGAACAGCGGGCCCCCGGCGAACGGGGAGACCGGCTGACGAGCGTGGACGCCGCCCGCGCCGTGGCGGTCTTCGCGATGTTCGCGGCACACATCGGCCCGCCGGCGAGGCCCGAGGGGGCGGGCCATCTGCTGGTCGCCCTCGACGGGCGCGCGCCCGCGGTCTTCACGCTGATCGCGGGGCTGTCGCTGTCGCTGTCCCGGGGCGGAACCCGCCCGCGCCCCGCGGCGAGGGGCGCCCGGCGCGGCACGCTGGTCCGCTGTGCCGTCCTCGCGGCGCTGGGCCTGGCTCTCGCGGAACTCAGGTCCGGGATCGCGGTCATCCTGGCCTTCTTCGCGGTGTACTTCCTGGCCGCCGAGCCACTCGCCCGGCTGCGGACGCGCAGTCTGCTCGTCGCGGCGGCGGTGTCGCCGGTGCTCGGGCCCGTGCTGTCGTACGTGCTGGGGCCGTACTTCGGCCACCGCGTGTCCGGCCGCGGCCGCTATCCGGGGTTCGACGCGGTCACGAGCTGGCCGGGGCTCCGCGACGCGCTGGACACCCTGCTGCTGTCCGGCGCGTACCCGTGGCTCACCTACTTCCCGTATGTGGTGGTGGGCATGGCGCTGGGCCGCGTGGTGGATCTGCGCAGGCCGGGCACGGCGGTCCGGCTCATCGGCTGGGGAGCCCTGGCCGCGCTGGCCGGCCACGGGCTGTCGGCGCTCGCGCTGGGGCCGGGCGGCGGGCGCGAAATGTTGCTGAGGGCCGTCGCCGACAGCCATCCGCTCGCGCTGAACGCCCCCGATCCGGTGCAGGCGGTTCTCGCCGCCCAGGCGGGCGCGATACCGAGCACCTCCTGGGCCTGGCTGCTGGTCGACGGACCGTACAGCCAGACGCCTTTCGAGACCGTCGCCAACATCGGCGCGGGTGTGCTGCTCCTGGGCCTCGCCGTCGCGGCCGGATGCAGCGGGCCGCTCCGGCCCCTGCTGCGGCCCCTGGCCACCGTCGGCACGATGGGGCTCTCGGTGTACGCCGTCCACGTCCTGGCCCGTGCCGAGTTGCGGCCCCAGCACGGCTGGGTGGCGCTGGGCGCGTTCTGCCTGGTCTCCCTGGCGGCCTGCGCACTGTGGGCGCGCGTCCTCCGCGGCAGGGCGCTGGGGCGGGGGCCGCTGGAGTGGGCCCTGCACGTGCTGGTGCGGGCCGCGACGTCGAGGAGAGGCGCGTCGCACCCCGGCGGAACCGGGGCGTAG	MLPPRDAGRNARPERPRFRASGRVPIHMGSTNRADPGRTTEPWPYNRFGGTTGDAGADQVVRTAGAAGPTGRERGERKRHETPGARGGPGERAGRGEQRAPGERGDRLTSVDAARAVAVFAMFAAHIGPPARPEGAGHLLVALDGRAPAVFTLIAGLSLSLSRGGTRPRPAARGARRGTLVRCAVLAALGLALAELRSGIAVILAFFAVYFLAAEPLARLRTRSLLVAAAVSPVLGPVLSYVLGPYFGHRVSGRGRYPGFDAVTSWPGLRDALDTLLLSGAYPWLTYFPYVVVGMALGRVVDLRRPGTAVRLIGWGALAALAGHGLSALALGPGGGREMLLRAVADSHPLALNAPDPVQAVLAAQAGAIPSTSWAWLLVDGPYSQTPFETVANIGAGVLLLGLAVAAGCSGPLRPLLRPLATVGTMGLSVYAVHVLARAELRPQHGWVALGAFCLVSLAACALWARVLRGRALGRGPLEWALHVLVRAATSRRGASHPGGTGA	MPSRPRTDSPHRHEGPAGPARLDRDEARRVWGQNFFRSAGSARRFARQLTGAESAGNDSVTVEVGPGAGRITKELVRDGHPIVAVEVDPHWADRLAELELPNLTVVNDDFTTWPLPDGPLRFIGNLPFGTGTRMLRRCLALGPDRCREGVFLLQKQYTRKRTGAYGGNLFNAQWEPWYTFRRGLGFPRQEFAPVPGSDTETLLVRSRPRPLAPWSRHAAYQRFVEDVFNTSRLTIGEAARALDRRAGPGWLRGARVPPGLRVKDITAEQWADLFHACTPPPARRISPQRRR	172.85	gnl|BL_ORD_ID|240|hsp_num:0	260		
BGC0001382.1|Svaricin_30 # 33836 # 34582 # 1 # ID=1_30;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.727	BGC0001382.1|Svaricin_30 	33836	34582	+	Loose	500	26.9498	mphI	38.24	3003991	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	TTGCACTGGATCGACGGCACCTGGGTCGGTCCGGGAAGCCGTGACGGCACTGACGTCCGTCCGGCGCCGGGGGAGCAGAGGACTGACGGGACCGCGGGCGACGGTCGCGAGATGGCGGCACGGGCGGTCGCGGCGGCCCGGCGGGCCTTCGGCGAGACGCGCTGGAAGGACGACCGGCATCTGCGGGCCAGGACCCTGCACGAGATGGCGGACGTCTTCGCCGCGCACGTCGGGCAGTTGACCGAGGCGCTGGCCCAGACGGACGGAAGGCGCAGGCAGCACGCGCGCTTCGAGGCGGAGGCGGTGCCGTCGCGACTGCGCTACTTCGCCTCGCTCGTGCGCACCGAGCACGGCCGTGCCCTCGAAGCCGCCCCGGGGAAGTGTTCCCTGGTCCTGCGGCGCCCCCGAGGCGTGACGGGAATCGTCGTACCGCGCCGGTCCCCTGTGGTCGTGCTCATCTGCTCCCTGGCCCCGGCCCTGGCGGCCGGTACGACCAGTGTGGTGGGGATGCCGGAGCAGACGGCCCGCGTCAACTCCCTGGTCTTCGGGATCTTCTCCGAGATCGAGTCCCTGCCACGCGGCGTCGTGAACGGGTTCACGGAGGAGGACGGCGCGGGCGCCCGGTATCTGGTGGCCGCCGCGGACGTGCCGTGCGCCCTCGACGGCAGCTCCCGGGAAGCGTCGGCGATGGAGGACTTCGTCGAGTGCGAGCGCGTGACCATCACCCCCGGAACGATTCAGCGGTAG	MHWIDGTWVGPGSRDGTDVRPAPGEQRTDGTAGDGREMAARAVAAARRAFGETRWKDDRHLRARTLHEMADVFAAHVGQLTEALAQTDGRRRQHARFEAEAVPSRLRYFASLVRTEHGRALEAAPGKCSLVLRRPRGVTGIVVPRRSPVVVLICSLAPALAAGTTSVVGMPEQTARVNSLVFGIFSEIESLPRGVVNGFTEEDGAGARYLVAAADVPCALDGSSREASAMEDFVECERVTITPGTIQR	MTIAKPNDDYTQVIQEMLEIAGKHGVNLIPEGIEMNESGMDFLVGFAEEAGTGARWILRKPRRPDVLDRADNEARVLKLIQSHLSVDVPDWRIYTPELIAYPLLSGQPAASVSMEGYAWNMDHENPGDGFIRSLAEALVALHGVDHDAARAAGLRVKSPQEVRDETARNMEDIKSRLGVSDALWERWQKWLEEDSYWPTHSALIHGDLHPPHILIDERVQVTGLLDWTESEVASPAKDFVLYYAIYGEHNLRVLLDRYEQAGGKVWPRMFDHIVEQHAAYPVLIAQFALLTGQEEYMTMARNALGLTE	80.52	gnl|BL_ORD_ID|2297|hsp_num:0	2527		
BGC0001382.1|Svaricin_31 # 34573 # 35118 # -1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.755	BGC0001382.1|Svaricin_31 	34573	35118	-	Loose	700	28.1054	ADC-76	23.0	3003882	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	GTGGCGTCGTGGGCCTACCCCGTGCCGTTCCCGGGGATGCTCTCCCTCGTCGCGGCCACGTTCCTGGAGCGCCGCGCACCCGCGGACACACCCCCCTCGGTCGCCCTCACGGTCCACTGCGCCACCAGTGCGGTGGTGTTCACCGCCCTCGCCTCGGCCACGGGGGCCGCCGCACCTCCCGCCGGCACCTCCTTCTGGACGGCCGTCGTCTGGCTGGTGGCGCTCTCGACCCTCGGCGGGTACGGCCTGTACTGGCTGGTCCTGCGCCGCTCCGGGGTGACCCGGGTCAATGCGCTGATGTTCCTGGTGGCGCCCGTGACGGCCGTGTGGGGAGCGCTGCTCCACGGGGAGCCGTTCGGCGCGCAGACCGGGATCGGCGTGGCCGCGGCCCTCGCCGCGGTGGCGATCATGCACCGGTGCGGGGATGGCGGCGGTGGCGCCGGTCCCCGTCCGCACCGGATCGGGGCCGGTCACACCGTTGCGCATGACGCCCCGTCAACCGCTCCCCGCGTGCGGGGAGCAGGCCCGGAACGCCGCTACCGCTGA	MASWAYPVPFPGMLSLVAATFLERRAPADTPPSVALTVHCATSAVVFTALASATGAAAPPAGTSFWTAVVWLVALSTLGGYGLYWLVLRRSGVTRVNALMFLVAPVTAVWGALLHGEPFGAQTGIGVAAALAAVAIMHRCGDGGGGAGPRPHRIGAGHTVAHDAPSTAPRVRGAGPERRYR	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVLKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGESRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	47.26	gnl|BL_ORD_ID|2514|hsp_num:0	2365		
BGC0001382.1|Svaricin_32 # 35672 # 37747 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.735	BGC0001382.1|Svaricin_32 	35672	37747	-	Loose	1750	27.7202	amrB	31.25	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGTGGCACCGAAGCGTTCCCCGGTGACCTGGTACCGAGCGTGGAGGTCGGCCCCGCCCCGCCCGGCGGGCTGCTCGACGTGCTCGGTCTGGCACCGGTGGTGCTGGACGCGGAGGGGCGCATCGCCCTGTGGAGCCAGCAGGCCGAGGAACTGCTGGGCTACACCGCCGAGGAGGCGCTCGGGCAGTACGCGCTGCCGCTGCTGGTCGAGGAGGATCACATCGGCACCGTCCTCGAGCTGTTCTCGAGCGTGATGGAGAGCGGCGAGAACTGGGCCGGCGTGTTTCCGGTGCGGCACAAGGACGGGGCGGTCCGTCAGCTGGAGTTCCGCAACATGCGGCTCCAGGACCAGCACGGCGGCTTCTACGCCCTGGGGCTGTCCACCAGCCAGGAGACCCTCCGCCAGGTGGAACGGGACCTGGCCCTGTCCGTGCGACTGGTCGACCAGTCGCCGATCGGTCTGGCCGTCCTCGACCCCGACCTGCGGTGCGTGACGGTCAATCCGGCCCTGGCGGGCGTCAGCGGGCTGCCGGCGGAGCAGCACGTGGGGCGCCGCGTGAGCGAGACCCTGCCGTTCCTGGACGCCGCCCGGCTCGAGGCGGCCATGCGCCGGGTGCTGGAGACCGGCACGCCGATGGTGGACCGCCAGGTGCTCGGGCGCACGCCGTCCGACCTGGACACCGAGCGCGCCTGGTCGGTGTCGCTGTACCGGCTGGAGGACCCCCGCGGCCGCATCCTCGGGGTCGCCGTGTCCGTGGTGGACGTGACGGACCGGCACCACGCCGCCAAGGAGGCGGAGCGGGCCCGGCACCGGCTCTCCCTGGTGGCCGACGCCTCGATGCGCATCGGCACCACCCTGGACCTGTGGGAGACCGCCCGGGAGCTGGCCGACGTCACGGTGCCGGAGCTCGCCGACATCGCCGCGGTGGACGTGCTGGACTCCGCGGTCGAGGGGCGCCGCGAGTCGGTGCAGGAGGGCGGCACGGCGGTGTTCCGTGCGCTCGCCGTGGCGGCTGCGCATCCGACCGTCGCCGTGCAGGCCGCCGACCCGCCGGGGGAGATCACCCGTTACGAGGCGGACCGGCTGGTCACGCAGTGCGTGCAGACGGGCGAGCCGATCGTGGTGCCGCGCGTGGCGAACGAGGACCTGCCCCGGATCGCGCGGGACGCCTCGGCGTCGGTGCTGCTGGCGGCGGCGGGGGTGCACTCGTACATGGCGGTGCCGCTGATCGCCCGCGGGGAGGTGCTGGGGGCACTCGACCTGAAGCGGTTCCGCAACCCGGTCCCGTTCGACTCCGACGACGTGCTGCTGGCGAGCGAACTGGCGAGCCGGGCCGCGGTGTGCATCGACAACGCCCGCTGGTACCAGCAGCAGCGCAACGCGGCGCTCGCCCTCCAGCGCAGTCTGCTGCCCCGGCATCCGCCGAACCTGGTGGGGCTGGAGGTCGCCTCCCGCTACCAGCCCGCGGGAGCGGTCAGCGAGGTCGGCGGCGACTGGTTCGACATCCTGCCCCTCAGCGACGGCAAGACCGCGCTGGTGGTGGGCGACGTGATGGGCAGCGGGATCAACGCGGCGACGGCGATGGGCCGGCTGCGCACCGCCACGCAGACGCTCGCCTCCCTGGGCCTGGGGCCCGACGAGGTGCTGCGGCACCTGGACTCGATCACCGGTGAGCTGGAGCCGTACATCGCGACGTGCCTGTACGCGCTGTACGACCCGCACCAGGGCCGTGTGTGCATCTCCACGGCCGGTCATCTTCCGCCGGTGCTGCTGCGGCCCGGTGAGGCGCCCGTGCTGCTCGATCTGCCCACCGGGGTGCCGCTGGGCGTCGGCGGAGTGGAGTTCTGCTCCGTCGACTTCGCCCTGGGTCCCGGCGACACCCTCGTGCTCTACACCGACGGTCTGGTGGAGACGCGCGACCAGGACATCGACGCCCGGCTGCATGTGCTGCTCACGCTGATGGCGGGGCCCGCCGCCGGGCTGGAGGAGACGTGCGACCGCCTCCTCGACTCGCTGCGGCGGGGCCCGGTGGAGGACGACGTCGCGCTGCTCATCGCGCGCGTGCGGGAATGA	MGGTEAFPGDLVPSVEVGPAPPGGLLDVLGLAPVVLDAEGRIALWSQQAEELLGYTAEEALGQYALPLLVEEDHIGTVLELFSSVMESGENWAGVFPVRHKDGAVRQLEFRNMRLQDQHGGFYALGLSTSQETLRQVERDLALSVRLVDQSPIGLAVLDPDLRCVTVNPALAGVSGLPAEQHVGRRVSETLPFLDAARLEAAMRRVLETGTPMVDRQVLGRTPSDLDTERAWSVSLYRLEDPRGRILGVAVSVVDVTDRHHAAKEAERARHRLSLVADASMRIGTTLDLWETARELADVTVPELADIAAVDVLDSAVEGRRESVQEGGTAVFRALAVAAAHPTVAVQAADPPGEITRYEADRLVTQCVQTGEPIVVPRVANEDLPRIARDASASVLLAAAGVHSYMAVPLIARGEVLGALDLKRFRNPVPFDSDDVLLASELASRAAVCIDNARWYQQQRNAALALQRSLLPRHPPNLVGLEVASRYQPAGAVSEVGGDWFDILPLSDGKTALVVGDVMGSGINAATAMGRLRTATQTLASLGLGPDEVLRHLDSITGELEPYIATCLYALYDPHQGRVCISTAGHLPPVLLRPGEAPVLLDLPTGVPLGVGGVEFCSVDFALGPGDTLVLYTDGLVETRDQDIDARLHVLLTLMAGPAAGLEETCDRLLDSLRRGPVEDDVALLIARVRE	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	66.25	gnl|BL_ORD_ID|441|hsp_num:0	476		
BGC0001382.1|Svaricin_33 # 37870 # 40302 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.728	BGC0001382.1|Svaricin_33 	37870	40302	-	Loose	500	26.1794	OXA-322	20.25	3001510	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAGAGTGATGACCGGATCCGTGACCCTGATCAGTGAGAGCCCGGAGGACCCGTTCTCGCTGGGGCGGGCCATCTCCGTCGTGCTGGACGAGCGGGGGTCGGTGGTCGGCTGGAGCGAGCGCGCGCGCGAACTCCTGGGGTTCACGGACCAGGAGGCCCTCGGGCGCCCCGCGGAGCACTTCCTCGTCGACGCGCGCGACCGCGGTCTCGTGCGGGAGGCCGCGGTCGACTGTGTGCGGGACGGCGGCTGGTTCGGGGTGGTGCCGGTCCTCGACAAGGAGGGCCGCAGGTCCCGTTTCGGGGTCCGGGCCAGACGGGTGATACGGGAGGGCCGGGCCGACGAGTGGCTGCTGGTGGGCGCGCCGGCCGAGGAGGTCGCCCAGTGGGAGATCGACCGGTCGGTGATGGAGGGGCTGTTCCGCCGCTCTCCCATCGGCCTGTCGGTGCACGACCCGAATCTGGCGATCCTGCGGATCAACCGGCCGATAGCCCACATCGGCGGGATCACCAGCGACCAGGCCCGGGGCCACCGCATCGGCGACTTCCTGGTGGCCGCGGACGCCGAGACGATCGAGTCGCGGCTCAACGAGGTCCTGGAGACCGGGACGCCGATGATCTTCACCGAGCAGCCGTGCCGGCTGCTCATCGAGCCGGGGATCGAACGGTACGTCGCGGTCTCGGCCTTCCGCATGGAGGACTCGGGCGGCCGGACGCTCGGGGTGACCCAGCTGGTCGAGGACGTCACCGACCGGCACCGGGCGCGCCGCCGGCTGGCGATGCTGAACGAGGCGAGCGAGCTGATCGGCACCACGCTCGACGTGGAGACCACGGCGCAGGAGCTGGTGGACGTCGCCGTGCCCGGTATCGCCGACTGTGTGACGGTCGACCTCCTGCCGGCCGTCGGACTCGGCGAGGCGCTGTTCCCGGAGCGCGGTGGTCCGCTGCGCAGGGCCGCGTTCAAGTCGGTCGCGCCGTACCCCGAGCGGGTGATCTACCCGGTGGGCACGCTCAGATCGTTCCCGAAGGACTCGCCGCAGGCCCGGTGCCTGGTGAGCCGGCGCCCCGTGCTGGTGCCCCGCATGGATCCCGGCGACGGGGGCCTGGACGCCGAACGGGCCGAGCACGCGCGGACGCTGGGCGTCCACTCGCTGATGGTCGTGCCGCTGACCGCACGGGGCCTGGTGCTGGGCCTCGTATGCCTGTGGCGGTACGTCGTCCCGGAGCCGTTCGAGGAGGACGACCTGACCCTGGCGAACGAGTTCGCCGCCCGGGCCGGGGTCGCCATCGACAACGCCCGCCGCTACACCCAGGAGCACCGGACGGCGCTGGCCCTGCAGCGCCGGCTGCTGCCGCGCGAGGTCCCCTCGCAGCCGGCGGTGCGCGTCGCGCACCGGTATCTGCCGGCCGGCGGCTCCGCGGGGGTGGGCGGTGACTGGTTCGACGTGATCCCGCTGTCCGGGGCCCGGGTCGCGCTGGTCGTCGGCGACGTCGTGGGCCACGGCATCAACGCCGCCGCGACGATGGGCCGGCTGCGCACCGCCGTGCACACGCTGGCCGATCTGGACCTGGAGCCGGACGAGGTGCTGTCCCACCTCGACGACCTGGTCACCCGGCTGGCCGGGGAGCAGGAGCACGGCGACGAGGGCTCGCCCGGCGAGCAGGTGGTGGGCGCCACCTGTCTGTACGCCGTGTACGACCCGGTGTCCCGGATCTGCTCCGTGGCCCGCGCCGGCCATCCGCCGCCGGCGCTCGTCTCGCCGGACGGCGAGGTGAGCCTGCCCGATCTGCCCGCCGGGCCTCCGCTGGGTCTCGGTGGGCTGCCGTTCGAGTCCGAGGACCTGGAGCTGCCGGAGAACAGCGTGCTCGCCCTGTACACCAACGGGCTCATCGAGGGCGACGCGTACGACGTCGACGCTGGTCTCGACCGGCTGGCGGAGGCCCTGGGCGGCCGGGACCGGCCGCTGGAGGACATGGCCCAGTCCGTGGTGGACGCGCTGCTTCCGGCGCGGCCCACCGACGACGTGGCCCTGCTGCTGGCCAGGACCCGCACCCTCGCGTCCGAACAGGTCGCGACCTGGGTGCTGCCCGCCGAGCCGACCACCCCGGCGCGGGCAAGGGTGCTGACCGCGGAGAAGCTGACCGAGTGGGGCCTGGAGGAGATGATCTTCACCACCGAGCTCGTCGTGAGCGAACTCGTCACCAACGCCTACCGCTACGCCGGCGGCCCGGTGACCCTGAGACTGATCCGTCTGCACCGTCTGATCTGCGAGGTCTCCGACCCCAGCAGTACCTCACCGCATCTGCGGCGGGCCCGCAGTACCGACGAGGGCGGCCGCGGGCTGCTGCTCGTGGCACAACTGACGTCACGGTGGGGTACACGGCACGCACATGAGGGCAAGACTGTCTGGACCGAGCAGGAGCTGCCGGGCTGA	MRVMTGSVTLISESPEDPFSLGRAISVVLDERGSVVGWSERARELLGFTDQEALGRPAEHFLVDARDRGLVREAAVDCVRDGGWFGVVPVLDKEGRRSRFGVRARRVIREGRADEWLLVGAPAEEVAQWEIDRSVMEGLFRRSPIGLSVHDPNLAILRINRPIAHIGGITSDQARGHRIGDFLVAADAETIESRLNEVLETGTPMIFTEQPCRLLIEPGIERYVAVSAFRMEDSGGRTLGVTQLVEDVTDRHRARRRLAMLNEASELIGTTLDVETTAQELVDVAVPGIADCVTVDLLPAVGLGEALFPERGGPLRRAAFKSVAPYPERVIYPVGTLRSFPKDSPQARCLVSRRPVLVPRMDPGDGGLDAERAEHARTLGVHSLMVVPLTARGLVLGLVCLWRYVVPEPFEEDDLTLANEFAARAGVAIDNARRYTQEHRTALALQRRLLPREVPSQPAVRVAHRYLPAGGSAGVGGDWFDVIPLSGARVALVVGDVVGHGINAAATMGRLRTAVHTLADLDLEPDEVLSHLDDLVTRLAGEQEHGDEGSPGEQVVGATCLYAVYDPVSRICSVARAGHPPPALVSPDGEVSLPDLPAGPPLGLGGLPFESEDLELPENSVLALYTNGLIEGDAYDVDAGLDRLAEALGGRDRPLEDMAQSVVDALLPARPTDDVALLLARTRTLASEQVATWVLPAEPTTPARARVLTAEKLTEWGLEEMIFTTELVVSELVTNAYRYAGGPVTLRLIRLHRLICEVSDPSSTSPHLRRARSTDEGGRGLLLVAQLTSRWGTRHAHEGKTVWTEQELPG	MYKKVLIVATSILFLSACSSNSVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRASTNYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQFAYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	296.70	gnl|BL_ORD_ID|1930|hsp_num:0	2047		
BGC0001382.1|Svaricin_9 # 11231 # 11698 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.718	BGC0001382.1|Svaricin_9 	11231	11698	+	Loose	500	25.0238	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid	46.43	3004157	protein variant model	E40Q	n/a	para-aminosalicylic acid	antibiotic target alteration	aminosalicylate resistant dihydrofolate synthase	ATGACGACGGCGGCAACCCGGTCCTTCACCACCGAGGAGCTCGCGTCGCTGCCGGCGGGGGAGCACCTCGGCCACAGCACCTGGCACGGCGTCCCCCAGAGCCGGATCGATCTGTTCGCCGAGGCCACCGGCGACCACCAGTGGATCCACACCGACCAGGCCGCCGCGGCCGAAGGCCCCTTCGGCGGCACGATCGCCCACGGCTTCCTCACGCTCTCCCTGCTGCCCCTGCTGACGTCCGAGGTGTACGACGTCACCGGTGTGTCGGCGGCCGTCAACCACCGTGTCGACAAGGTGCGTTTCCGATCCCCGGTCCCCGCGGGCGCCAGGGTGCGGGCCGGAGTCGACCTCGTCTCGGTGCGACCCCGCCCCCGCGGCTACACGGAGGTGACGGTGAAGGTCGCCATCGAGCTGGAGGACGGCGGAACCGCCTGCACCTGCGAGCAGACCACGCTCTACCGGGCCTGA	MTTAATRSFTTEELASLPAGEHLGHSTWHGVPQSRIDLFAEATGDHQWIHTDQAAAAEGPFGGTIAHGFLTLSLLPLLTSEVYDVTGVSAAVNHRVDKVRFRSPVPAGARVRAGVDLVSVRPRPRGYTEVTVKVAIELEDGGTACTCEQTTLYRA	MNSTNSGPPDSGSATGVVPTPDEIASLLQVEHLLDQRWPETRIDPSLTRISALMDLLGSPQRSYPSIHIAGTNGKTSVARMVDALVTALHRRTGRTTSPHLQSPVERISIDGKPISPAQYVATYREIEPLVALIDQQSQASAGKGGPAMSKFEVLTAMAFAAFADAPVDVAVVEVGMGGRWDATNVINAPVAVITPISIDHVDYLGADIAGIAGEKAGIITRAPDGSPDTVAVIGRQVPKVMEVLLAESVRADASVAREDSEFAVLRRQIAVGGQVLQLQGLGGVYSDIYLPLHGEHQAHNAVLALASVEAFFGAGAQRQLDGDAVRAGFAAVTSPGRLERMRSAPTVFIDAAHNPAGASALAQTLAHEFDFRFLVGVLSVLGDKDVDGILAALEPVFDSVVVTHNGSPRALDVEALALAAGERFGPDRVRTAENLRDAIDVATSLVDDAAADPDVAGDAFSRTGIVITGSVVTAGAARTLFGRDPQ	31.83	gnl|BL_ORD_ID|2481|hsp_num:0	2804		
BGC0001382.1|Svaricin_25 # 28872 # 29774 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0001382.1|Svaricin_25 	28872	29774	+	Loose	660	25.0238	MexS	32.56	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCGCGCTCGGCGACCTCATCAGCGCCGACGAACCCACCTTCTCCTTCGAGTTCTTCCCCCCGAGGACCGAGGCCGGGCAGCGGTCGCTGCTCCGCGCGATCCGCCGCATCGAGGCCCTGACGCCGTCGTTCGTGTCGGTCACCTACGGAGCCGGCGGCTCCTCGCGCGACCGCACCGTCGAGGTGACGAAGCGCATCGCCGCCGAGACCACGCTGCGCCCGGTGGCCCATCTGACCGCCGTCGGCCACTCGGTGGCGGAACTGCGGCACATCATCGGCCAGTACGCGGACGCCGGCATCCGGGACGTGCTGGTGCTCCGCGGGGACCCGCCCGGCAGCCCGCGCGGGCCGTGGACGCCGCACCCGCAGGGCTTCGACTACGCCCATCAACTGGTCTCCCTGGTCAGGGGGCTGGGGGACTTCAGCGTCGGCGTCGCGGCCTTTCCCGAGTGCCACCCGCGCTCTCCCGACCGGGACAGCGACATCCGCCACTTCGTCGCCAAGTGCCGGGCCGGGGCCGACTACGCCATCACCCAGATGTTCTTCCACGTGGAGGACTATCTGCGGTTCCGCGACCGGGTCGAGGCCGCCGGCTGCGAGACCCCGATCATTCCGGGGATCATGCCGGCCACGGACGTGCGCCAGATCCGACGGTTCTCCGAGCTGAGCGACGCCGCGTTCCCGGAGGACCTCGCGCACCGGCTGGAGGCCGCCCGCCAGGACCCCGGCACCGCCCACCGCATCGGCGTCGAGTACGCCACCGGCATGGCGCTGCGGCTCCTCGCGGAAGGCGCTCCGGGGCTGCACTACATCACCCTCAACCGCTCCGACGCCGCAGCCGACATCCACCGCAACGTCATGAGTGCAAGGAGTTCCGATGTCCTCTCAGGACACCGCTGA	VSALGDLISADEPTFSFEFFPPRTEAGQRSLLRAIRRIEALTPSFVSVTYGAGGSSRDRTVEVTKRIAAETTLRPVAHLTAVGHSVAELRHIIGQYADAGIRDVLVLRGDPPGSPRGPWTPHPQGFDYAHQLVSLVRGLGDFSVGVAAFPECHPRSPDRDSDIRHFVAKCRAGADYAITQMFFHVEDYLRFRDRVEAAGCETPIIPGIMPATDVRQIRRFSELSDAAFPEDLAHRLEAARQDPGTAHRIGVEYATGMALRLLAEGAPGLHYITLNRSDAAADIHRNVMSARSSDVLSGHR	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	88.50	gnl|BL_ORD_ID|1067|hsp_num:0	1041		
